<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004200057
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        JIVI powder and solvent for solution for injection
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PEGYLATED B DOMAIN DELETED RECOMBINANT HUMAN COAGULATION FACTOR VIII DAMOCTOCOG ALFA PEGOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        IU
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder and solvent for solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        3504.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Bayer Healthcare LLC Biological Products Division" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Bayer Healthcare LLC Biological Products Division
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2947]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Bayer Saudi Arabia
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAYER HEALTHCARE LLC
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B02BD02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jivi contains the active substance damoctocog alfa pegol. It is produced by recombinant technology without addition of any human- or animal-derived components in the manufacturing process. Factor&nbsp;VIII is a protein naturally found in the blood that helps to clot it. The protein in damoctocog alfa pegol has been modified (pegylated) to prolong its action in the body.</p><p>&nbsp;</p><p>Jivi is used to <strong>treat and prevent bleeding</strong> in previously treated adults and adolescents aged from 12&nbsp;years with haemophilia&nbsp;A (hereditary factor&nbsp;VIII deficiency). It is not for use in children younger than 12&nbsp;years of age.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-right:-.1pt"><strong>Do not use Jivi </strong>if you are</p><p style="margin-left:28.35pt; margin-right:-.1pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->allergic to damoctocog alfa pegol or any of the other ingredients of this medicine (listed in section&nbsp;6).</p><p style="margin-left:28.35pt; margin-right:-.1pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->allergic to mouse or hamster proteins.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p><strong>Talk to your doctor or pharmacist if you have</strong></p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->tightness in the chest, fall in blood pressure (often shown by feeling dizzy when getting up quickly), itchy nettle-rash, wheezing, feeling sick or faint. These may be signs of a rare severe <strong>sudden allergic reaction</strong> to this medicine. S<strong>top injecting the product</strong> immediately and get medical help at once if this occurs.</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->bleeding that is not being controlled with your usual dose of this medicine. Speak with your doctor immediately if this occurs. You may have developed antibodies against factor&nbsp;VIII (inhibitors) or antibodies against polyethylene glycol (PEG). These make Jivi less effective at preventing and controlling bleeding. Your doctor may carry out tests to confirm this and ensure that your Jivi dose provides adequate factor&nbsp;VIII levels. Your doctor may switch you back to your previous factor&nbsp;VIII treatment, if needed.</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->previously developed factor&nbsp;VIII inhibitors to a different product.</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->heart disease or you are at risk of heart disease.</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->to use a central venous access device for this medicine. You may be at risk of device-related complications where the catheter is inserted including:</p><p style="margin-left:43.6pt; text-indent:-14.2pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->local infections</p><p style="margin-left:43.6pt; text-indent:-14.2pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->bacteria in the blood</p><p style="margin-left:43.6pt; text-indent:-14.2pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->a blood clot in the blood vessel</p><p>&nbsp;</p><p><strong>Children</strong></p><p>Jivi is not for use in children younger than 12&nbsp;years of age.</p><p>&nbsp;</p><p><strong>Other medicines and </strong><strong>Jivi</strong></p><p>Jivi is not known to influence or be influenced by other medicines. Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.</p><p>&nbsp;</p><p style="margin-right:-.1pt"><strong>Driving and using machines</strong></p><p>Jivi has no influence on your ability to drive and use machines.</p><p style="margin-right:-1.45pt">&nbsp;</p><p><strong>Jivi contains sodium</strong></p><p style="margin-right:-.1pt">This medicine contains less than 1&nbsp;mmol (23&nbsp;mg) sodium per dose, and is therefore considered to be essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Treatment with Jivi will be started by a doctor who is experienced in the care of patients with haemophilia&nbsp;A. After suitable training patients or carers may be able to give Jivi at home.</p><p>Always use this medicine exactly as described in this leaflet and as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The dose of factor&nbsp;VIII units is measured in International Units (IU).</p><p>&nbsp;</p><p><strong>Treatment of bleeding</strong></p><p>To treat a bleed, your doctor will calculate and adjust your dose and how often it should be given, depending on factors such as:</p><p style="margin-left:.5in; text-indent:-.5in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->your weight</p><p style="margin-left:.5in; text-indent:-.5in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the severity of your haemophilia&nbsp;A</p><p style="margin-left:.5in; text-indent:-.5in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->where the bleeding is and how serious it is</p><p style="margin-left:.5in; text-indent:-.5in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->whether you have inhibitors and how high their level is</p><p style="margin-left:.5in; text-indent:-.5in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->the factor&nbsp;VIII&nbsp;level that is needed.</p><p>&nbsp;</p><p><strong>Prevention of bleeding</strong></p><p style="margin-left:1.05pt">To prevent bleeding your doctor will select an appropriate dose and frequency depending on your need:</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->45&ndash;60&nbsp;IU per kg body weight every 5&nbsp;days or</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->60&nbsp;IU per kg body weight every 7&nbsp;days or</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->30&ndash;40&nbsp;IU per kg body weight two times per week.</p><p>&nbsp;</p><p><strong>Laboratory tests</strong></p><p>Laboratory tests at suitable intervals help to ensure you always have adequate factor&nbsp;VIII levels. For major surgery in particular, your blood clotting must be closely monitored.</p><p style="margin-right:-.1pt">&nbsp;</p><p style="margin-right:-.1pt"><strong>Duration of treatment</strong></p><p>Usually Jivi treatment for haemophilia is needed lifelong.</p><p>&nbsp;</p><p style="margin-right:-.1pt"><strong>How Jivi is given</strong></p><p>Jivi is injected into a vein over 2&nbsp;to 5&nbsp;minutes depending on the total volume and your comfort level. The maximum rate is 2.5&nbsp;mL per minute. Jivi should be used within 3&nbsp;hours after reconstitution.</p><p style="margin-left:28.35pt; margin-right:-.1pt; text-indent:-28.35pt">&nbsp;</p><p style="margin-left:28.35pt; margin-right:-.1pt; text-indent:-28.35pt"><strong>How Jivi is prepared for </strong><strong>injection</strong></p><p style="margin-right:-.1pt">Use only the components (vial adapter, pre-filled syringe containing solvent and venipuncture set) provided with each package of this medicine. Please contact your doctor if these components cannot be used. Do not use if any component of the package is opened or damaged.</p><p style="margin-left:28.35pt; margin-right:-.1pt; text-indent:-28.35pt">&nbsp;</p><p style="margin-right:-.1pt">The reconstituted product must be <strong>filtered by using the vial adapter</strong> before injection to remove any possible particles in the solution.</p><p style="margin-left:28.35pt; margin-right:-.1pt; text-indent:-28.35pt">&nbsp;</p><p style="margin-right:-.1pt">This medicine must <strong>not</strong> be mixed with other injections. Do not use solutions that are cloudy or contain visible particles. Follow the <strong>instructions for use</strong> given by your doctor and provided <strong>at the end of this leaflet.</strong></p><p>&nbsp;</p><p style="margin-right:-.1pt"><strong>If you use more Jivi than you should</strong></p><p style="margin-right:-.1pt">Tell your doctor if this occurs. No symptoms of overdose have been reported.</p><p>&nbsp;</p><p style="margin-right:-.1pt"><strong>If you forget to use Jivi</strong></p><p style="margin-right:-.1pt">Inject your next dose immediately and continue at regular intervals as advised by your doctor.</p><p style="margin-right:-.1pt">Do not use a double dose to make up for a forgotten dose<strong>.</strong></p><p style="margin-right:-.1pt"><s>&nbsp;</s></p><p style="margin-right:-.1pt"><strong>If you stop using Jivi</strong></p><p style="margin-right:-.1pt">Do not stop using this medicine without checking with your doctor.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p><p>-------------------------------------------------------------------------------------------------------------------------</p><p>&nbsp;</p><p><strong>Detailed instructions for reconstitution and administration of Jivi</strong></p><p>You will need alcohol swabs, gauze pads, plasters and tourniquet. These items are not included in the Jivi package.</p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash your hands thoroughly using soap and warm water.</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hold an unopened vial and also a syringe in your hands to warm it to a comfortable temperature (do not exceed 37 &deg;C).</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the protective cap from the vial <strong>(A)</strong>. Wipe the rubber stopper on the vial with an alcohol swab and allow the stopper to air dry before use.</p><p style="margin-left:28.35pt; text-indent:-28.35pt">&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
   o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
   stroked="f">
   <v:stroke joinstyle="miter"/>
   <v:formulas>
    <v:f eqn="if lineDrawn pixelLineWidth 0"/>
    <v:f eqn="sum @0 1 0"/>
    <v:f eqn="sum 0 0 @1"/>
    <v:f eqn="prod @2 1 2"/>
    <v:f eqn="prod @3 21600 pixelWidth"/>
    <v:f eqn="prod @3 21600 pixelHeight"/>
    <v:f eqn="sum @0 0 1"/>
    <v:f eqn="prod @6 1 2"/>
    <v:f eqn="prod @7 21600 pixelWidth"/>
    <v:f eqn="sum @8 21600 0"/>
    <v:f eqn="prod @7 21600 pixelHeight"/>
    <v:f eqn="sum @10 21600 0"/>
   </v:formulas>
   <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
   <o:lock v:ext="edit" aspectratio="t"/>
  </v:shapetype><v:shape id="Grafik_x0020_11" o:spid="_x0000_i1034" type="#_x0000_t75"
   style='width:70.5pt;height:1in;visibility:visible;mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAF4AAABgCAYAAACUosWzAAAYuklEQVR4nO2da1AUV9rHp1K7mhKybNwPmw+bqlRSbtXuphJX7kowII7INcMdRGUKiGiIIhBBcMWCARTBKHLJIhAQIhBEQC4ichN0QEcBQQVFEIbLIIjIJdzx/36wppdheqa7ZwbMh/dX1R+mz+nTZ/40fc55nuc8wzI3NwebzYaJicn/H6twsNlsmJubg6Wmpoa0tDT09va+k2NgYAAvXrzAixcv0N/f/876sVpHWloa1NTUwFq3bh2Kioqw2oyMjCAuLg7Ozs6ws7ODjY0N3NzcEB4ejpKSEkxNTa16n1aDoqIirFu3bvWFn5ycxJ49e+Di4oKGhgYsLi5KlLe3tyMrKwtcLhfGxsY4deoUJicnV61/K807Eb65uRk6Ojro7e2lfc3du3dhZWUFX19fqT8SABw7dgxmZmawt7eHpaUlIiIiSOv9Xlh14cvKymBjYwMA6O7uRlRUFPLz89Ha2orZ2VnK6x8+fIjNmzcTfX39+jW0tLRw584diXp37tyBtrY2GhoaVP8lVMCqCl9RUQEnJyfis0AgwJo1a7Bu3TqsWbMG7733HtTU1PDpp5/i+vXrctuKjo6Gm5sbtm3bhpcvX8qs5+npiZCQEFV9BZWxasK3tbVh+/btEucEAgHWrl0LDQ0N4lBXV8fZs2dptZmYmIjMzEzKenl5eWCz2Xjz5o1CfV8JVkX44eFhaGlpSZ0nE15DQwOffvop5ufnKdvdtWsX7T50d3dj06ZN6OnpYdT3lWLFhZ+dncW///1vzM3NSZXJEl5DQwPW1taUbS99bdFhYWEBRkZGqKioYHTdSrDiwm/ZsgWDg4OkZQKBAO+//z4++ugjfP755xLCr127FpWVlQCAN2/eoKqqCgcOHIClpSWsrKzg4OAAFoulUJ+8vLwQGxur8HdSBSsqvK2tLQQCgczye/fuYf369RAKhXj+/LnU0/+vf/0LXC4XZmZm+Pnnn/Hq1Svi2paWFujp6aGgoEChvp0/fx4+Pj4KXasKVkx4f39/XL58WW6d7u5u9Pf3E59DQ0PxwQcfEMK///77qKqqIr02ISEBjx49wpYtWxTuY3Z2NlxdXRW+XhlWRPiUlBTweDzG1yUlJWHNmjUST/3BgwdJ6/r5+WFychJZWVlISUlRuK9OTk74/PPP8ezZM4XbUASVC5+RkYHDhw+TliUkJKC1tVXqfG1tLTZv3oz8/Hy4uLhICG9gYCBVf3R0FH/729+IzyYmJjLHEXlYWVkhISEBc3Nz2L9/P2xtbdHX18e4HUVQqfA5OTk4cOCA3Dq6urrEUn5sbAzffPONxH9Hamoq1NXVoaGhgXXr1oHD4UhcLxAIoK+vjx07dhDn5ubmsGnTJkYmgs2bN6O5uVni3NjYGPbt24edO3dSLuCURWXC3717F46OjpT12tvbcfToUVRVVUFXVxcvXryQKOfz+Vi7di0+/PBDXLx4UaLM29sb+/fvBwD88MMPeP36NVHW29sLPT09WuJzOBwp0ZcyPz+P1NRUbN++HY6OjkhJScHAwABlu0xQifAdHR0wMjKiXf8vf/mLzNdRQ0MD9u7dK2EOvnbtGvT19fHgwQPiXFJSEu7evStxbXd3NzQ1NTE0NCTz3jExMbh06RLtvi4uLqK6uhr+/v4wNzeHhYUFQkNDUVNTQ7o2oYvSwo+Pj5OuSmXh6upK+4vX19fD0NAQ8fHxUmUJCQlITk6WOj85OQl9fX2Ul5dLlQ0ODsLKyop2X2XR2dmJCxcuwNbWFubm5jhx4gRjS6jSwm/ZskXiX14eUVFR+PnnnynrXb9+HcbGxggPD5cqW1hYAJfLRVhYGHbv3i2zjZCQEHA4HIm5v4WFxYo4VpqamrBp0yaMjo7SvkYp4Q8ePIj6+nra9S0tLWWWjYyMgMfjwcDAAAkJCaR1rl27hvXr18PNzQ1hYWH4+OOP5d5vYGAA9vb2cHFxgbe3N23jmyJMTU0x+s9XWPimpibKGcxShoeHJYxaMzMzuHXrFkJCQmBkZAQPDw+Jd/hSHjx4gB07diAxMRGPHj2CUCiESCRCUlIS6StlORMTE1KD+EogEAhkrjuWo7Dwenp6jDtmZmYGKysrcDgccLlcJCYmoqOjQ2b9+/fvw9DQEB999BF4PB4iIyMRHh6O9PR0oo6pqSnjfqwkXC4XQqGQsp5Cwufk5CA1NZVxp+rr63H69Gm5dRYWFpCWlgYDAwP4+Pigvb0dIpEIfX19GBwcRGtrK/bs2UPUDwsLw61btxj3ZaWYnp6GnZ0dZT2FhDc2Nla4Y2TXjo+PIzc3FzY2NtDS0kJmZiZGR0chEokgFApRWVmJiIgIHD16FOfPn5e6nmx1+y7x8vKifLUxFv7169c4dOiQwp3q6OjA3//+dzg5OcHW1hYWFhbw8PBAYWEhACA+Ph4RERGIiIgAj8fDmTNnUFFRgenpaam2JicnERUVBRMTE7i5uSncJ1XT29src50ihrHw2dnZSi+n5c1uqOjo6EB0dDR27twJR0dH3Lt3DwDw008/ISoqSql+qZKlJg0yGAt/4sQJRmEZZBgbG8PJyQkVFRX47bffSOuMjo5CIBDgl19+weHDh2FtbQ0LCwuEhITg/v37pNcEBQXhv//9r1J9UxXp6ekoLi6WWc5Y+GPHjkksShRh3759GB8fR2pqKry8vGBtbQ1XV1fY2trCysoKNjY28PHxQWJiIiorK2kv0ADgs88+w6lTp5Tqn6qQ575kLPzp06fR2dmpVIfS0tLA5/OVaoOszS+++AKtra1ITk6Gs7OzSttXBFdXV5krZcbCV1dX48KFC0p16MGDBzh37pxSbQBAY2MjDhw4AF1dXRw+fFhiGtfc3AxtbW2lHxJlaGpqQmhoKGnZqk8nxWzdupXxNV1dXUhNTYWrqyuMjIzg7++PxsZGjIyMwNPTUyrqYHZ2Fh4eHnB1dcXw8LBUexMTEwqtR5jw9ddfk55XSPioqCiUlZWRlg0MDNAaA5qbm7F161Z89913iI6OxpUrV5CdnY3s7Gzk5OTgzJkz8PPzg4uLC0xNTWFkZISDBw8iOzsbvb296OvrQ2dnJzo7OyESieDo6IizZ8+iqalJ6l5DQ0Nwd3fHjh07cObMGTQ1NREmXXE44UpRWFhI6ppU2GSgq6srdS45ORm2trbYt28fnJycaAUlNTc3Izg4GFpaWsjPz0dWVhYuXbqEyspKPHjwAAMDAxgYGEBPTw8h9PJDJBLB1tYWc3Nz0NPTg0gkknu/mJgYuLq6wsbGBv/4xz9I62VnZ9PWggp9fX2pcwoLX1xcLGHbvnbtGvz8/IjPXV1d0NTUpBVabWlpCT8/P7S0tMgUV97R398PW1tbAMCrV6+wd+9ecDgcWjaT1NRUlJSUSJybn59Xid1eTGNjI7799luJcwoLr6WlhcjISJSWlgIgf5e9evUKmpqapKvOpTg4OKC+vh5nz55VSHihUCgl1MTEBKytraXch2R89dVXEp/DwsLQ2NhIeR0T/P39cfPmTeKzQsI7Ojqiu7sbwNtXztDQEHx9fUnrikQiSregi4sLgLdPfnd3N2Phe3p6YG5uTtq2h4cHpc8gIyNDYpBVxeSBDF1dXeINwFj4J0+eSERgdXV1YcOGDXIjuioqKhAYGCizXGxtNDc3x+DgIGPhnz9/TgySZPcxNDSk/F7btm3D4OAgOjo6Viyse2xsDJs3bwaggPCWlpZYWFiQOHfkyBHKQFB3d3c8fvyYtGzv3r0A3i75+Xw+I9G7uroIT9P3339P2j6Px5Nr9wfeepB0dHRw5swZtLS0yK2rDJWVlfD390dpaSl94ScmJuDu7i51vr29ndLODsh2nojDQhoaGhAWFkZL7P7+fty/fx/BwcHYt28fPD098ejRI9L2nzx5InMhs5S2tjaFA2GZ8N133+Ho0aP0hT937pzM9yWbzaa84eXLl0kHu127diEzMxP9/f1gs9kYGhoitiX29fWhv78ffX19EAgESEpKQmBgIHx9fREZGYlnz56hu7sbZ8+elRi8lrM8MEoWq2Vq+Oc//wkNDQ16wsvr/JEjR9De3k55Q7KBVjwjKS8vx8aNGxESEoLAwEAEBwcjICAAAQEBCAoKQlxcHPh8PkQikdQgnJ6ejqtXr8q8r3i6SQXTmHtFKSgooP/EOzg4yCxbXFykNYhFRkZKxE8ODAwgICCA+BwVFYUbN25AKBRCKBSip6cHz58/p5zHs9lsufGTdB0lqyU8o8GVqlMXL16kNKC1trZKhFn4+/tLDHzt7e3w8/OjNbD29vaioaEBmpqalNEGsbGxMqMYAKCmpgZ9fX2wt7eX246qYCS8vCdeDJvNlhtn+PLlSxw/fhzA28F627ZtUnV0dXVRWVkJkUiEnp4edHd3o7u7G0KhEAMDA2hvb0dCQgKMjIywd+9eWrYhPp8v86EIDAwkZkS/yyeeTlDqzMwMtLW1ZZaPjIzgP//5D4C3EbtkcY4zMzPw8fEBm83Gzp07YWFhAUtLS5iamsLMzAzu7u4oKCiQmtbKY3p6Gl5eXlLnbWxsCH8vAERERODJkye021UURsLTCVsA3k7LZM1y+Hw+vL29oa2tTTm3VjXffPONxOc9e/ZIzYTa2tpWxXfLSPgTJ07Itfwt5c6dO6RO7f379+PChQty4x5XiqUzm6SkJCQmJpLWYxL5rCiMhL969SquXLlCu/G6ujqw2WzC/ZWcnEz8u6vS+keX/fv3Y2pqClNTU6RjixgejycVAq5qGAk/MjKCI0eOMLpBf38/jI2NYWZmhqysLOK8s7Pzqid5uHDhAu7duwculyv3P3dubo4yPENZGNtqLCwsVHLjc+fOgcvlYmJiQiXt0QmRbmlpQWxsLC2v08mTJ1d0Ow5j4Tdu3KiSQbG8vBx3795FaGgoQkNDaTktljI2NoaCggKcPHkSx48fJ0zLVPz5z38mfAhU6OnprVj+A0bC79u3D1lZWVLeFEWYmJhAXFwc8Tk3NxchISGIjIxEdHQ0zp8/j9jYWOKIiYlBdHQ0oqKiEBwcjPT0dIn1QkZGBi1v14cffki7j8+fP1fZf/hyaAtfXFxM2KkV6UxZWRnYbDbs7OzA5XLh6OgIY2NjuLi4ID09HWNjY4p+BwDAs2fPcOPGDcp6dG02YnJzcxEcHKxot2RCW/ilEbnZ2dmUu7aZUFFRgV27dsHc3FzubjwqfvzxR8o6hw8fZrRlBgA+/vhjlTtHaAmfl5eHX3/9VeLcSvwLLi4uwt/fn3aEwnIiIyMp62RmZqKmpkbq/NOnT0lnWbW1tUhKSsKPP/4If39/xn2SBS3hyQYuLpeL8fFxlXVkKZ2dndDS0pIZnCqLmJgYyjpPnz6Viq1sbW0lXTTxeDxs2LCByKdQXFwMExMTlWxgoyU82fSrra2NsLmsFHv27EF0dDTt+idPnqRVb6khrK2tjTSqjcPhEI6bpXGefX190NfXVzruhpbwsoxjssLTVElqairtqeLly5dp5TQQ25yePn1Kupvk0KFDqK6uBvDW9EEW5peWlgZtbW2FxzpawsuaCcTFxaGurk7qfG5uroRzQ1nu3r0rFftCRn9/v1wvlBgbGxvMz8+TWlFbWlqIbfti5BkHL168KNf8IAtawsuyUS8sLEg5DmZnZ6WSvqmCrq4uaGlpUQZH0bEsRkREYOPGjZiZmZEqI9tF6OrqSts4SBelhAek/bAJCQkK7cKbmZmhHKyHh4exadMmuekO6QgfEBBAmo9yYGCAdO/u3NwcrZyYTFB4cBVTVlYmEQ3LJDMeADx+/BhsNhvOzs74/vvvYWlpCWtra3z77bcoKiqS+sLDw8OkAbNiqISfn5+XssuLKSgo+H3lq6Fa7S2NhhVvBqNDSUkJOBwOqT1kenoaGRkZ4HA44HA4EplU79+/D29vb9I2z5w5I/eeycnJxMD5LqElfExMjNwVZVFREWOvzcuXL7Fz505adWdmZhAeHg5DQ0OiH7t37ybdbHDt2jW5RrzV8qlSQUv4V69ewdPTU25Dzs7OjBY87u7ucvPKyMLb2xuenp4YHByUCAsXMzo6ipycHJnX0/Ebrwa0bTWyonGX8tVXX9F2FCuTg6C5uRnGxsYy/bryFl1Lp4bvMg8CbeEFAgHCwsIoGzQ1NaVcVMzOzjLK/EHG4OAg/vjHP5KWBQUFEWHkyxELHxQURGqzWS0Y2eNNTExoNSreeS1rI/LDhw9VkjumpKSENEtTWFgY+Hw+6uvrMTk5CaFQSAzgDg4OEAqFRITyu4KR8Hw+n7Z5dHx8HB4eHnB0dJQKcHr06JGEE0QZyMwJ8fHxqKurQ3V1NaqqqlBVVUVsSjtw4IBCK01Vw9j1t3PnTkaBROI9Sbt37yYyWgiFQlph03QgW2PU1dUR08bq6mrU1NSgqqoKd+7cgZub2+8imT9j4dvb2ykzU5AxNDQEFxcXcLlcTE9PqyzVCVkw6uzsLAICApCbm4va2lpcvHgRNTU1yMrKeuevGDGMhR8fH8f69esVclQAb/dE2dvbQ1tbm7EbbjllZWUyk8t5e3ujvLwcBQUFqKmpAZ/Ph6am5u/md0MYC6+pqYk7d+5IWfCYMjw8DHd3d9phgWQsnw6OjY3h0qVLCAgIAI/Hw82bN1FaWorq6mqEh4fLjBx7FzAS3t3dndh8YGdnR2kppINAIICenh7j3MB5eXn4+uuvERMTg6NHj8LDwwNeXl7Iy8vD7du3UVNTQ7zj6+vr5QbSvgtoCz89PS2x6nv48CHtjHNUjI2NwdzcnJazGnib28zAwAC1tbVoaGiQEPrGjRv49ddfJYQ/f/48aUqtdwlt4ePj43H79m2Jc3Tn9XTZsGEDtLW1ERQUJDPG/tSpUzA1NSWmi0uP8vJyXLlyBTdu3CDO1dbWwsjI6HfzbhdDW3gyc69AIFAoT7wszMzM0NjYiJiYGHA4HBgYGMDR0RHHjx+Hs7MzdHV1cerUKYmneflx8+ZNiSe+vr7+nQTIUkFbeFk2eVUuRrhcLvh8Pqqrq3H16lXU1dWBz+ejqKgIt2/fxq1bt1BeXo7CwkK54i89rl+/vmo/SVFWVoacnBzU1tZS1qUtvKy9QbW1tbQiAR4/fky5aGpuboaLiwshNpmQFRUVxJycSnw+n4/Y2FgkJSVR9k9ZFhcXwWKxwGKxZNqQlkJbeHlbLekE8uvo6FDWAf4Xu5Kbmws+ny8hblVVFXJycoiV6HKh6+rqUF9fj8zMTHh4eBBbd1Y6CT/wNhpCLDyLxaI0wNEWXt7G21u3bsm1XJ4+fZo0GkEW4+PjCA0NhYWFBezs7HDixAmkpKSgqKgIpaWlKCkpQUlJCbKyshAXF4fg4GA4OjpCU1MTtra2iI2NJX70JT8/n1ZMpbJs2bIFLBYLWlpaYLFY4HK5cuvTFl6Wn1LM9u3bSb32wNtBU1GmpqZQW1uL5ORk8Hg8+Pr6wtfXF/7+/oiNjUVOTg7u3buH2dlZiEQibNmyRcKWtBrC//bbb8ST3tPTAxaLhT/84Q9yr6EtvKenp1zjmNgUQIaypgHgf1EIVN7+J0+eSKQdLCwsZJyenSlxcXFgsVjEw/nXv/4VLBaL+AExMhjN46n2BYWFhUllOwJA6TaUxfz8PBwcHGBlZQVPT08cOnQIHh4esLa2hpWVFaysrODj44PCwkKJn41ITU0ltv20tLTgp59+Uuj+dPnyyy/BYrGQl5cH4K2ThcViyd1gR1v48fFxWqF0xsbGUg4QqvedLHR0dGR6kpb269KlS7C1tQWHwyF2byuS5U8RXr58SbxmOBwO7O3tYWhoCBaLhffee0/mdYxsNVwuV+KXyshYXFyEpqamRAw61fhAhqenJ+lvRsljZmYG/v7+cHFxQWBgoELOdKacPHlSYjaz/JA1o2Ik/MzMDK2p4+TkJL744gsi2SaTFLUA8OLFC6WyY7e3t0NDQ4M0FaKq+eyzz8BisRAfHy+x9d/NzQ0sFktmgBdjs3BGRgapn3M5b968gZOTEwIDAxnb7g8dOsR4M9pyiouLVzzB87Nnz4gnezkNDQ0yywAFk8Gx2WzaQZxNTU3Q0dFhJIKqjG90khcpw8DAAGpqamRGz4kXeWSb4hQSfmpqirF9u6CgAPr6+pQ/Azo+Pq4yc/O72LZPF4XzTgoEAtL8ZFSkpKRAX19fZorcmzdvMvplMnnweDylX1krhcLCA29H9KUitba2EnNZKuLj42FgYCD1e60lJSW026DCz89PZTvHVY1SwgNvp4risD1xTkUmxMTEYOvWrRKrPEXaIWOlEzYrAyG8uro6jh07hitXrjA6CgsL8cknnyA+Ph5eXl6Mr8/Pz0dxcTH09fXx5Zdf4pdffoGfnx/Mzc1RWFjIuD3xUVpaCk1NTRQXFyvcxkoex44dg7q6OlgaGhpQV1eHmpoa4+NPf/oT1NTU8MEHHyh0vfhY2gdxm8ocqmhjpQ7xb9b+Hwp8xwAq7RWwAAAAAElFTkSuQmCC" /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Place <strong>the powder</strong><strong> vial</strong> on a firm, non-slip surface. Peel off the paper cover on the plastic housing of the vial adapter. <strong>Do not remove</strong> the adapter from the plastic housing. Holding the adapter housing, place over the product vial and firmly press down <strong>(B)</strong>. The adapter will snap over the vial cap. <strong>Do not remove</strong> the adapter housing at this point.</p><p>&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Grafik_x0020_12" o:spid="_x0000_i1033"
   type="#_x0000_t75" style='width:70.5pt;height:70.5pt;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image003.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,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" /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hold the pre-filled syringe of solvent upright. Grasp the plunger rod as per the diagram and attach the rod by turning it firmly clockwise into the threaded stopper <strong>(C).</strong></p><p>&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Grafik_x0020_13" o:spid="_x0000_i1032"
   type="#_x0000_t75" style='width:70.5pt;height:70.5pt;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image005.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,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" /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Holding the syringe by the barrel, snap the syringe cap off the tip&nbsp;<strong>(D)</strong>. Do not touch the syringe tip with your hand or any surface. Set the syringe aside for further use.</p><p>&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Grafik_x0020_14" o:spid="_x0000_i1031"
   type="#_x0000_t75" style='width:70.5pt;height:70.5pt;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image007.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,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" /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Now remove and discard the adapter housing&nbsp;<strong>(E)</strong>.</p><p>&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Grafik_x0020_15" o:spid="_x0000_i1030"
   type="#_x0000_t75" style='width:70.5pt;height:1in;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image009.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAF4AAABgCAYAAACUosWzAAAcUUlEQVR4nOV9d1RUZ/6+u5sTExU8m2z2bI5bdDf/5JjEPZE2IwhIc+hDkzICShOkOHRphi4wgAiIRIxIFaRZQEWliIXiMAPMAIJCFNfCRpeVuICiz+8Pz9wfA1PuDCOafJ9z3nOYez/ve9/7cO9bPu0uMzExgaGhIfT19X/RhUajQU9PTyFtGRkZwcDAQOZ6W7dulSpjaGgIExMTLFu5ciUKCwsxNjb2iy2PHz+GoaEhfvrpJ4W0FxwcjKamJpnrBQQEgMfjSZQpLCzEypUrsWzFihU4c+YMfumwtbVVWFsUCkWuejt37pQqc+bMGaxYseLXQfz169eRk5OjkLZqampw7Ngxuera2NhIlflVER8TE4O7d+8qpC1NTU2569rZ2UmV+VURT6fThX4/fPgQbDYb586dQ19fH549e7agzvT0NCYmJoSOFRUVobi4WO5+/J8j3s7ODmNjY3BwcICRkREiIiKQk5OD6upqZGdnw8fHByYmJrCyssLJkyeRnp4OCwsLhISEgE6nw97eHgMDA9DW1l5UPxwcHKTK/GKIHxoaQk5ODpycnGBpaQk6nQ4rKyvY2NjA1tYW5ubm+Pzzz+Hh4YH//ve/UtvbsGEDMXl2dHSAxWIhPDwcpqam8Pb2lrufHA4HBw8elCr3XhM/NjYGX19faGtrY9++fejq6sLs7KxIWUtLS1y5coVUu/r6+mhvb4eZmRkAIDExkTiXm5sLX19fmJuby9XnuLg4DA4OSpV7L4kfHR0FjUaDn58fHj58KFVeTU0NjY2NUuUmJyehpqaG27dvAwDq6+uxf/9+vH79Gu7u7oRceXk58vLy4OfnJ3PfDQ0NScm9d8T7+/vD1dUVk5OTUmVnZmawYcMGuLq6SpX98ccfoaqqikePHhHHpqen4ePjg5qaGkxOTsLf3x+1tbV49OgRMjIy4OzsjKdPn5Lu+82bNxEVFUVK9r0hfnx8HKqqqujs7CQl/+rVK6irq8PR0REPHjyQKNvd3Q0qlYpXr14Rx/Ly8nD16lUAQEBAAIKDgwEAIyMjqKqqAgDcuHED33//Pel70NbWxuvXr0nJvhfEj4yMQFVVldRTDvx/0icmJmBiYiJRtrq6esFutqCgADdu3BA6duPGDaioqGD//v0YHh7GvXv34OTkhN7eXlJ9ys/PR1FRESlZ4D0g/vHjx1BXV5epDoVCwejoKGZmZuDh4SFWrry8HAEBAULHiouLJU7Cvb29SEhIQEJCAv7xj3/gwIEDUvvT29sLS0tL8jeA94B4FRUVvHjxQqrc1NQUWCwW1q1bR0yOt27dQlZWltg6FhYWQr+TkpLQ3NwsVn5ychLl5eUAgOfPn2PXrl3w9PSUOPw1NTVBX19fav/n450S7+Ligv7+fqlylZWV0NHRwZo1azA0NEQcHxoakvhECoaYvr4+REdHg8/nS7wOi8Ui/s7Pz0dbWxsAiHwjnz17Bnd3d7lWPsA7JL6rqwuBgYFS5Xx8fJCSkoLCwkKcPXtW6Nz4+DgiIyPF1nVzc8Pz589J9yk6Opr429TUlPibw+GAwWCgoqICsbGxsLOzA51Ox48//ki67fl4Z8RraGhIldmzZw9OnToFANDR0REpI0kNPDg4CF9fX1L9uXLlCtrb28W2q6enh8uXL2NkZIRUe9LwTojv6upCfHy8RJnW1laEh4cDAB48eIDQ0FCRctJ2mB4eHuju7pbap5iYGOLv0tJS4h8uQHNzM/Lz86W2QxbvhHh7e3u8fPlSooyWlhbxd3V1Nc6dOydSLjc3lxiLxUFdXR3379+XKJOZmUn8bWVlJVLG2NhYYhuy4J0QL+0GWltbhQwaBw4cEDsJz87OCo3HovD69WtQqVSJa/K51xM3fFlbW0u8jixYcuI5HI7EJSDwxnQ2d1JMS0vD8PCwWPmAgAAMDAxIvfb27duFJtC5uHjxIgCgoaEBx48fFymzY8cOqdcgiyUn/sCBA+ByuRJl5r/qlZWVaGpqEiv/+vVr0vbRtrY2UCgUHDx4EFNTU0LnXr58CSqVKlYD+osmnkzn7e3thX7zeDykpqZKrNPY2ChxaTkfra2tsLe3h6WlJaysrGBpaQkjIyNicyYKZGypZLHkxJPxAhA1uZEZX5lMpthJWBH45JNPUFdXp5C2lpz4+U8zWRmyhgkzM7MFCjBFoK2tDTExMYs2CwrwXhIvSuF07tw5HD16lNQ1rKysUFJSInPfJGH9+vUYHBwEi8XC9evXF93ekhNPZpzctm2byOOyuFykpKSAwWCInSjFYWZmBn19fWhvb0d9fT3YbDZCQkKwbt06QobBYMjUpigsOfFkXB9yc3NFagSrqqpkMkwMDw9DTU1N4n2Nj48jLS0NVlZWoNFo8PDwQHp6OvLz83H69Gnk5ubi0KFDCA8PB41Gg62tLf7whz8gNTUV7e3tQsYVWbDkxIeEhEg1pz19+lSsjkVHRwfT09MyXfPgwYOgUCgoLCwkiOJyuTAyMiKtUpiPwcFBZGdnw8LCAlu3bgWLxcK9e/dI119y4k+cOIFLly5JlROn4x4fH5dL/w282RyZmJhARUUFoaGhMg9DksDj8RAcHAxtbW2Eh4dL3dAtOfEPHz4ktd6uqakRa0qrra3F3r17Zb72kydPoK6uvih1LhmMjY0hOjoaenp6cHJyQklJyYK3oaGhYel1NQYGBqTkNm3aJPZcbGws8vLySF/z559/hqamJthsNqqqqlBWVoampiZ0dnbi3//+N+l2ZMXU1BQuXLiA6OhoWFlZwcLCAtbW1qBQKFBWVl5a4t3d3Um95o2Njdi/f7/Y86GhoVL1PgJQqVSoq6sjOTkZ9fX1uHLlCuE/ExwcDBsbGxgbG4PBYODkyZML1AmKxjvRTl69epU0YaampvjXv/4l9nxubi6cnZ0ltmFkZIT6+npS15uenkZdXR1MTEzg7u6O//znP6TqyYp3ZoEiuwN88eIFNm7cKFGmq6sLampqIl20s7Ky0NDQIE8X8fDhQ2hoaMi0WiGLd0Y8i8VCa2srKdmenh6p7hPT09NgMBjw8/MTUinTaLRF9VOarl9eEMSvXLkSsbGxaGtrA4/HQ29vL549eyZUFI0tW7aQlq2rqyNlP719+zaMjY3h5eUFDocjtxeAAGRUHPKAIH7VqlWIjo7GsWPHkJmZiaysLAQEBBDF29sbdDodhoaGsLCwwKFDhxZ98czMTJw/f560/PHjx+Hm5kZKdnx8HG5ubosKzenq6lLIfYqC3ENNY2MjVFVV8dNPPy2qA7J6kV2+fBm6urqkVkXXr19flLKsoqKCsEwpGosa4ycnJ6Gurg4OhyN3B9hstszDwejoKDZu3Iienh6Jck+fPkVYWJjcfcvPz5d6DXmhkMnV1tYWZWVlcnfCz89PLh26m5sbdu/ejZmZGbEy4vxxyCA/P1+qmVJeKGxVs3fvXnz33Xdy19+0adOCIDAyGBoagra2NpKTk0VuelgsFi5fvixXn0pKSiT6Wi4GCl1OlpWVyR3g++zZM6ioqMh97Rs3boBGo8HFxQUdHR1C51RUVEi7gM9FU1PTot5kSVD4Or6jowO6uroSX39xGBkZAZVKXdT1JyYmkJGRARqNBisrK8TExKCkpATr1q2TeSFw7949xMXFLao/czHXXvtWNlD37t3Dt99+S/pG//e//xGReqOjo9i8ebNC+gG8cf9raGhAeXk5tLW1UVpaKlN9Jycnma/Z2toq0mYw1/r21naugkCv+RFws7OzKCwshIWFBb755huYmZnB29sbu3fvBp1Oh7OzMxgMBr788ku5hgdpKCwshKamJhITE4VcvsVBHu8xcYb5uZuxt64y0NPTI3Qlzc3N2LhxI6ytrREVFYWBgQFwuVx0d3eju7sbXC4Xw8PD0NHRQXFxMT777DOJfi6LwdDQEGJiYmBqagpTU1P4+PjgwIEDOHXqFC5evIjz58+joaEBGzZskLnt+QERAsyd/5ZEV+Pv7w9vb28YGxujrKyM8CYTED63dHR0wN7eHsHBwWhuboauri4OHz78Vvo1FwIjd3V1NQwMDLBu3TqcOHFCLrfs7du3izw+1968JMTfv38fSkpKuH//PlxcXMDj8USS3t3dDR6PBxqNhoCAAAwODoLP5yM+Ph46OjpSo/sUidHRUZiZmSEiIoJUqNBciCN+rrPukhBPoVBgYGCAM2fO4OjRo2JJ53A4CAoKwrp161BSUoL4+HhwuVxwOBy0t7dDS0sL0dHRCrWVSkJ2djaOHDkCCoUiUwoVce4fc+2wb514JpOJkpIS0Gg0xMXFoaenRyzxzc3N0NbWBpvNxoYNG5CVlYXQ0FBiLrh79y6MjY3x7bffEkFibwN37tyBr6+vkE+9kZERtmzZItXPHiDn9fZWie/s7MS2bdvA4/Fgbm6O6OhoDA4Oih1iqFQqbty4ge7ubtTX1+Orr77CsWPH4OXlhaCgILi6uuLmzZugUCgwNjbGX//6V8TGxkq0UMkCHo+HiIgInDhxYsE5Op2O2dlZGBsbS7We2draSvW3eavEf/PNN+jr6wOXy4WZmZnEJ57D4cDS0lJo0mWz2bCxsYGBgQFiY2Nx8OBBaGpqgsViwdnZGePj40hOTsZvf/tbMBgMsFgsXLx4UabNG5fLRXp6OmJjY8Xef2lpKU6fPk38FkQhijMLkrHXKpx4gTMShULB2bNnCVIZDAYKCgpQXFwskviBgQGoqamhv79f6DiXywWfz4eDgwMiIiLQ2dkJDoeD/v5+IvvG9PQ0PD094eXlhfb2dmRnZyM2NhZpaWlgsVhIT0/HwYMHkZGRgaysLLBYLMTFxSExMVGi370AoqxfT548AZVKJZW8QhQUSnxKSgq0tbXR2NgIPp8vRKCnpyfa29vh7+8PDocjkvyioiLo6ektIL+lpQXa2toL2kxJSSHyEQBvdql0Oh1+fn5SY6zI4tWrVxIT/0RFRZFK/jYfCiH+0aNHMDExQUpKCvh8PvLz8xeQ6uHhgStXrmDXrl1ihxsul4u8vDyoqqqirq6OWE6qqqri+vXrIt8SHx+fBf0ZGBiArq6uUMCwvDhy5AguXLggUYbD4UBFRUWmfGgiiefxeKQbSEhIwLJly3D48GFwuVwEBwejo6NjAUmhoaGorq7GtWvXJD71gk3Uzp07oaurCy0tLZSUlIiU6+vrk2gTbWxshJqaGioqKqTex+XLl5GZmYk7d+4IHZeWpEKA6elp0Ol0qZErAogknmwQgLGxMSgUCnx8fNDT04P+/n7s3r0bvb29C0jat28fKioqwOFwEBUVhYaGBrHEC+YFHo+Hvr4+iTK2trZSfV+KioqgoqIiNiyzt7cX1dXVAN6otgsLCwG8yWcga9zTmTNnQKVSF0Shi5JbQDwZxZCdnR327NkDKpVKrES4XC7CwsJEDgnHjx/Hli1biKWjg4MDurq6JJIvrfT29sLAwICUEywApKamQktLC7du3RI63tHRIWQBy8nJwczMDFJTU9HV1UWq7fn44YcfYGJiAjqdjsDAQBw9ehQtLS1EximRxJ8+fVpsyKGgUlRUFLy8vMBkMoknvK2tDampqULk3Lx5E1988QXi4+NRX1+Pr7/+Gj/88AMGBwdha2tLrNvlKXw+H9ra2jJtpmZmZhAQEAAzMzOhbE2+vr4YGxsD8CafzdTUlMLCbiYmJnDt2jUUFxeDyWTC0NAQmzdvhpKS0sLJVdJFKRQKiouLUVNTg5CQEIKI+cT39fXByMgIcXFxSEtLI572nTt3wtzcHDweDwwGA1VVVWKVZpKGmYiICCQnJ5Maw+fjyZMncHFxgaurK2ELKCwsRFJSEiorKzEwMIB9+/bJ3C5ZVFdXv8ktrKSkBFNTUzg7O8PQ0BC2trYin3oOhwMmk4mAgAB0dnYiMzNT6AkMDg4mfh85cgR79uyBqqoqBgYGhFYvtbW1WL9+PWpqapCYmAg/Pz9wOByJk+7c+sePH0dERAR8fHwkBh9Lw927d2FmZobAwEDCaev169fQ1NTEzz//LHe70iBxOWljY7PA+h8dHY2mpiYEBgbi6tWryMjIECLe398fvb296OnpgZaWFoyNjUUuBQVvhJ2dHRgMBthsNtzc3MBkMnH16lXw+fwFb4Gg3eDgYCQlJaG7u3vRpkIBbt++je3bt4NOp8PU1JRUHp3FQOo6nkajCW1SbGxsMDIygpCQEPD5fOzdu1fo9d+zZw94PB4sLS0RFRWF7777TuoEWVpaiq+++gqnT59GT08PoqOj4evrCz8/P4SHhyMsLAyBgYEICAhAYGAg0tPTsWXLFqxevZp0rsn3DaQ2UC4uLoQrm52dHUH88PAw/Pz8hJ7MtrY2WFlZYdeuXdi0adOCXaik4cPU1BTu7u7g8XjE8nRwcBB3797FpUuX4OTkBAqFgqSkJLS0tCg00nqpQXrnmpOTA0dHR1hZWWF4eBhMJhODg4PYvXs3MX739vaisLAQW7ZsgaWlJVpaWmSaMPv6+nD48GF8/fXXuHTpEtrb2xEZGQl1dXW4urqiqakJfD6f2M3KaqB4nyCTyuDOnTv429/+hsHBQYSEhIDH44HFYuH06dPg8XhwdHREcHAwmEwm6HS6xM2PpNLZ2QkjIyMYGhri6NGjGBgYEJp09+/fj4KCgiWi6O1AJuLLysrw+eefo7GxESdPnkRBQQHu3LkDOzs7bNy4EVVVVdDQ0EBxcTEOHTqEvLw8mUnn8XgICgrC4cOHRe6Au7q6FDahvkuQJj4/Px8RERFoa2vDvn37MDw8DEdHR6ioqCA5ORkFBQXQ0NAAm80mhh0mk0mohsmW3NxcYpMhivigoCDcvHlz0Tc+MTGBo0ePIjk5edFtyQNSxDc3NwsFBWhpacHa2powPujo6EBHRwd37txZsLP09fVFeXk5qfV5d3c3tLW1sXXrVrS3t4s8HxcXJzfxbDYb+/btw4YNG/Cb3/wGSkpKcsfMLhakiFdTUxP67erqikOHDkFfXx9mZmbo7+9HZWUlkpOTRQ4dMTExSExMXKBPnz+xGhsbY+/evcQafW7p7+/H999/j/3798u1ozQ1NcXvfvc7rF69Wqh8+eWX8vC2aEglfufOnSI3EwIvsfj4eJw9e5ZQkNXW1opcKlZVVcHBwQFtbW0i1QPHjh2Dv7+/yCUon8+Hp6cnGhsbsXPnTmzevFku38zs7GysWLFCiPhPP/1ULuIWC4nEd3V1LcjNK4CtrS1aW1vB5/Nhb28PHo8HPp+PHTt2oLm5WeRTzefzwWQy4enpidbWVsK/pqenB5qamjAzM8PVq1eF/mHt7e1wdHREfX09YRB//PgxqWSh82Fvb7/giV+2bJlcxC0WEomX5Db9/PlzqKmpgc/nE94EfD4f/f39cHZ2FjupCvTs0dHRcHd3R3h4OCwsLBAZGYmEhATweDy0tbUhPz8ffn5+8Pf3J96QtrY2LF++HAD5BPkCnD9/Hh9++KEQ6R9//DE++OADmXLEKwpCxM9V3nt4eIDNZkusXFxcjNDQUHA4HDQ0NGD37t3Ek79nzx5kZWVJXMsLDB1OTk4wMjJCWFgYgoKCkJCQgNraWvT39xOTcm9vL5ydnbFmzRoAb1yeyX655uXLl/j9738vRPonn3yClpYWfPrpp+jr65OfQTlBEK+srAwTExM8f/4cbDabdGpYZ2dnwnPgxIkT2LVrF/h8Pnp6elBQUABXV1eJq5iysjJkZ2fD1NRUrGqYw+EgPz8fhoaGQnkQyMagWlpaCpH+4YcfEkFl09PTC8x9SwGhJz4nJwfGxsb45z//KVMjWlpaxNDS0NAABwcHcLlcsNlscLlcuLu7IyIiAjweb8GykslkIjc3FwkJCWLfioyMDKSlpcHe3h4hISHEdbdv307KcWj58uVCxCsiw9JiIUR8fX099u7dK1cg2KZNm1BZWQkOhwM2m41t27ahtrYWPT094HK5aG5uxo4dO8BkMtHS0oL+/n7weDzo6+sjMTERFy5cWDARnz9/Hi4uLigtLUVgYCDs7e2FhoXKysoFOYDnYmpqCsrKykKkf/bZZwr3vbx9+zZOnDiBioqKBaW0tFSkTkmI+PT0dIk+Ii9evMDNmzdRX1+PhoYGgizB0o5OpyMlJQV9fX3g8XhISkqCu7s7urq6wOVyCbeOuLg4eHp6IiQkhMj5WFtbi9LSUqSlpcHf3x9eXl5ISkrC8PAwkpKSkJeXtyAn2cTEBIKCgsT218zMTIj05cuXv5VgskOHDmHZsmVii6jvUhHEr169Gn/605+ETk5PT+PkyZOEG92OHTtw5MgRZGZmgkql4qOPPsLatWuxZs0a0Gg0eHp6YvPmzbCwsBAygAcEBMDHxwfNzc3EZNvT04ORkRGYm5uDwWCgsrISJSUlaG1txa1bt8Dj8dDV1QU3NzcijEbUWCzOMF9ZWYmPPvqIIF1ZWVlqlg95cfjwYSxbtgx///vfkZGRgdTUVKIkJCSI3HMI5TIQRLhxOBzY2NjAxsYGdXV1mJ2dxatXrwjfxbCwMJGpn2ZmZlBWVoa1a9fij3/8IzIzMwnNYm9vLyIjI+Hp6YnIyEhi1WJjYwMrKyuMjIwQw095eTl8fX3h7e0NHo8HOzs7sdF3ovxqJicnoaSkJPS0z3+oFAkB8bIYx4WIj4yMhJaWFmJjYwnHy+npaURFRcHAwIB0tg0AhBlNTU0NGRkZ4PP5xBqey+UiNzcXbm5uiI6OxhdffIHg4GD4+/sjICCA8EK4du0aNm3aRPi8iIIoY4iRkdGCVcy1a9dI911WCIgXpF6fmZkhijhXQoJ4JSUl+Pv7EydmZ2cRGxsLfX190p/kmQ99fX2Mj4+juLgYurq6sLe3R2FhIbHWP3nyJFJTU0Gn09Hf34/+/n4MDQ2hsrKSSCMl7ctn879oWVJSgo8//lhoiJH05RxFQEC8qCJuoydy51pUVAQ1NTWpGyhpePXqlVAC/qdPnyI3NxfW1tag0WhYv3494uPjQaVSYWJiAh0dHWhoaCA+Ph6PHz+W2v7Q0NCCL43t379faIf65z//eVH3QAYC4pWVlUGlUkGhUIgiTrUhkvhTp04p7EvABQUFQr7lkiAwnJDFtm3bRCZy4/P5WLt2LT744AOFpKOVBgHxsuTfEaurMTIyUljHtm7dSkpOT0+PdJtlZWVSjRiyBhPLCwHxsiSsEEv88ePH5c7lNR8MBkOqYbqlpQVr167F6Oio1Pbq6urERta9CwiI/8tf/oLw8HCEhIQQJTAwUGQGELHET01NwcvLSyEdq66uluo9K9CEmpqaIj4+XuTucnJyEu7u7mK/kPOukJubK3EDJerNk6gWJusbLg3379+XmFLF09NTaOXU3t4Oc3Nz2NjYICIiAqGhoaDRaLC2tiYVBr/UePDgAVpaWtDa2rqgtLS0iFwoSHXhUxQcHR1FHudwOGI1oVVVVSgqKnpruR/fJSQS7+3tLXPmanEQl8dmvj13PuTJnvFLgETiMzIyFJbEQVTeeIEDrKz1fg2QSHxFRYXcaaXmY76CamxsjBSpkiLufskQyjsZFRWFmpoaooSFhSE+Pl7omDyloKAATk5OxO9Tp05BQ0MDZWVlEuvV19dDQ0MDZ8+eXXQf3rcSFRWFVatWvVELr1q1CitXriTKqlWrFhyTtygpKQn9VlZWJlWPrNwvraxatQqrV6/G/wNozFzNkg7IPQAAAABJRU5ErkJggg==" /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attach the pre‑filled&nbsp;syringe to the threaded vial adapter by turning clockwise&nbsp;<strong>(F).</strong></p><p style="margin-left:28.35pt; text-indent:-28.35pt">&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Grafik_x0020_16" o:spid="_x0000_i1029"
   type="#_x0000_t75" style='width:70.5pt;height:1in;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image011.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,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" /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inject the solvent by slowly pushing down on the plunger rod <strong>(G)</strong>.</p><p>&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Grafik_x0020_17" o:spid="_x0000_i1028"
   type="#_x0000_t75" style='width:70.5pt;height:70.5pt;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image013.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,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" /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">10.&nbsp;&nbsp;&nbsp;&nbsp; Swirl vial gently until all material is dissolved&nbsp;<strong>(H)</strong>. Do not shake vial. Be sure that the powder is completely dissolved. Look to check there are no particles or discoloration before you use the solution. Do not use solutions containing visible particles or that are cloudy.</p><p>&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Grafik_x0020_18" o:spid="_x0000_i1027"
   type="#_x0000_t75" style='width:70.5pt;height:70.5pt;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image015.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,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" /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">11.&nbsp;&nbsp;&nbsp;&nbsp; Hold the vial on end above the vial adapter and syringe&nbsp;<strong>(I)</strong>. Fill the syringe by drawing the plunger out slowly and smoothly. Ensure that the full content of the vial is drawn into the syringe. Hold the syringe upright and push the plunger until no air is left in the syringe.</p><p>&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Grafik_x0020_19" o:spid="_x0000_i1026"
   type="#_x0000_t75" style='width:70.5pt;height:70.5pt;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image017.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,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" /><!--[endif]--></p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">12.&nbsp;&nbsp;&nbsp;&nbsp; Apply a tourniquet to your arm.</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">13.&nbsp;&nbsp;&nbsp;&nbsp; Determine the point of injection and clean the skin.</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">14.&nbsp;&nbsp;&nbsp;&nbsp; Puncture the vein and secure the venipuncture set with a plaster.</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:382.85pt"><p style="margin-left:28.35pt; text-indent:-28.35pt">15.&nbsp;&nbsp;&nbsp;&nbsp; Holding the vial adapter in place, remove the syringe from the vial adapter (the adapter should remain attached to the vial). Attach the syringe to the venipuncture set <strong>(J)</strong>. Ensure that no blood enters the syringe</p><p>&nbsp;</p></td><td style="vertical-align:top; width:81.55pt"><p><!--[if gte vml 1]><v:shape id="Bild_x0020_22" o:spid="_x0000_i1025"
   type="#_x0000_t75" style='width:70.5pt;height:1in;visibility:visible;
   mso-wrap-style:square'>
   <v:imagedata src="file:///C:/Users/GCHBV/AppData/Local/Temp/msohtmlclip1/01/clip_image019.png"
    o:title=""/>
  </v:shape><![endif]--><!--[if !vml]--><img src="data:image/png;base64,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" /><!--[endif]--></p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">16.&nbsp;&nbsp;&nbsp;&nbsp; Remove tourniquet.</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">17.&nbsp;&nbsp;&nbsp;&nbsp; Inject the solution into a vein over 2 to 5&nbsp;minutes, keeping an eye on the position of the needle. The speed of injection should be based on your comfort, but should not be faster than 2.5&nbsp;mL per minute.</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">18.&nbsp;&nbsp;&nbsp;&nbsp; If a further dose is needed, use a new syringe with product reconstituted as described above.</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">19.&nbsp;&nbsp;&nbsp;&nbsp; If no further dose is required, remove the venipuncture set and syringe. Hold a pad firmly over the injection site on your outstretched arm for about&nbsp;2&nbsp;minutes. Finally, apply a small pressure dressing to the injection site and consider if a plaster is necessary.</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">20.&nbsp;&nbsp;&nbsp;&nbsp; It is recommended that every time you use Jivi, you note down the name and batch number of the product.</p><p style="margin-left:28.35pt; text-indent:-28.35pt">&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:6.45in"><p style="margin-left:28.35pt; text-indent:-28.35pt">21.&nbsp;&nbsp;&nbsp;&nbsp; <strong>Do not </strong>throw away any medicines via wastewater or household waste. Ask your pharmacist or physician how to throw away medicines you no longer use. These measures will help protect the environment</p><p style="margin-left:28.35pt; text-indent:-28.35pt">&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>The most <strong>serious</strong> side effects are <strong>allergic reactions </strong>or severe allergic reaction. <strong>Stop injecting Jivi immediately and speak to your doctor at once if such reactions occur. </strong>The following symptoms could be an early warning of these reactions:</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->chest tightness/general feeling of being unwell</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->burning and stinging at the application site</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->nettle&ndash;rash, flushing</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->a reduction in blood pressure, which may make you feel faint upon standing</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->feeling sick (nausea)</p><p>&nbsp;</p><p>For patients who have received previous treatment with factor&nbsp;VIII (more than 150&nbsp;days of treatment) inhibitor antibodies (see section&nbsp;2) may form uncommonly (less than 1&nbsp;in&nbsp;100&nbsp;patients). If this happens your medicine may stop working properly and you may experience persistent bleeding. If this happens, you should contact your doctor immediately.</p><p>&nbsp;</p><p>The following side effects may occur with this medicine:</p><p>&nbsp;</p><p><strong>Very common </strong>(may affect more than 1&nbsp;in&nbsp;10&nbsp;people):</p><p style="margin-left:28.35pt; margin-right:0in; text-indent:-28.35pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->headache</p><p>&nbsp;</p><p style="margin-left:2.85pt"><strong>Common </strong>(may affect up to 1&nbsp;in&nbsp;10&nbsp;people):</p><p style="margin-left:2.85pt; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->stomach pain</p><p style="margin-left:2.85pt; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->nausea, vomiting</p><p style="margin-left:2.85pt; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->fever</p><p style="margin-left:28.35pt; margin-right:0in; text-indent:-25.5pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->allergic reactions (may present as hives, generalized urticaria, tightness of the chest, wheezing, shortness of breath, low blood pressure, for early symptoms see above)</p><p style="margin-left:28.35pt; margin-right:0in; text-indent:-25.5pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->local reactions at the injection site such as bleeding under the skin, intense itching, swelling, burning sensation, temporary redness</p><p style="margin-left:2.85pt; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->dizziness</p><p style="margin-left:2.85pt; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->trouble falling asleep</p><p style="margin-left:2.85pt; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->cough</p><p style="margin-left:2.85pt; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->rash, skin reddening</p><p style="margin-left:2.85pt">&nbsp;</p><p style="margin-left:2.85pt"><strong>Uncommon </strong>(may affect up to 1&nbsp;in&nbsp;100&nbsp;people):</p><p style="margin-left:2.85pt; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->taste disturbance</p><p style="margin-left:2.85pt; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->flushing</p><p style="margin-left:2.85pt; text-indent:0in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->itching</p><p style="margin-left:2.85pt">&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p style="text-align:left"><strong>To report any side effect(s):</strong></p><p style="text-align:left">The National Pharmacovigilance Centre (NPC):</p><p style="text-align:left">SFDA Call Center: 19999</p><p style="text-align:left">E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p><strong>Do not</strong> use this medicine after the expiry date which is stated on labels and cartons. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Store in a refrigerator (2&nbsp;&deg;C&nbsp;-&nbsp;8&nbsp;&deg;C). Do not freeze.</p><p>Keep the medicine in its original package in order to protect from light.</p><p>&nbsp;</p><p>This medicine may be stored at room temperature (up to 25&nbsp;&deg;C) for up to 6&nbsp;months when you keep it in its outer carton. If you store it at room temperature it expires after 6&nbsp;months, or the expiry date if this is earlier.</p><p>The new expiry date must be noted on the outer carton when the medicine is removed from the refrigerator.</p><p>&nbsp;</p><p><strong>Do not</strong> refrigerate the solution after reconstitution. The reconstituted solution must be used within 3&nbsp;hours.</p><p>&nbsp;</p><p><strong>Do not</strong> use this medicine if you notice any particles or the solution is cloudy.</p><p>&nbsp;</p><p>This medicine is for single use only. Any unused solution must be discarded.</p><p><strong>Do not</strong> throw away any medicines via wastewater or household waste. Ask your pharmacist or physician how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-right:-.1pt">The <strong>active</strong> substance is PEGylated B-domain deleted recombinant human coagulation factor&nbsp;VIII (damoctocog alfa pegol). Each vial of Jivi contains nominally 500 or 1000 or 2000&nbsp;IU damoctocog alfa pegol.</p><p>The <strong>other</strong> ingredients are sucrose, histidine, glycine, sodium chloride, calcium chloride dihydrate, polysorbate&nbsp;80, acetic acid glacial and water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Jivi is provided as a powder and solvent for solution for injection. The powder is dry, and white to slightly yellow. The solvent is a clear liquid. After reconstitution the solution is clear.

Each pack of Jivi contains
•	a glass vial of powder
•	a pre-filled syringe of solvent
•	a separate plunger rod
•	a vial adapter
•	a venipuncture set
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by:</strong></p><p>Bayer HealthCare LLC</p><p>Berkeley, USA.</p><p><strong>Final release by:</strong></p><p>Bayer AG</p><p>51368 Leverkusen, Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 11/2021.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="text-align:right">يحتوي جيڨي على المادة الفعالة داموكتوكوج ألفا بيجول. يتم إنتاج المادة الفعالة من خلال استخدام التكنولوجيا في إعادة تركيب المادة النووية بدون إضافة أي مكونات مشتقة من الإنسان أو الحيوان في عملية التصنيع. العامل الثامن هو بروتين موجود بشكل طبيعي في الدم يساعد على تجلطه. تم تعديل البروتين في داموكتوكوج ألفا بيجول (دمج وحدات متكررة من البولي إيثيلين جلايكول المرطبة كيمائياً مع بعضها بجزيئات البروتين في داموكتوكوج ألفا بيجول) لإطالة المدة الزمنية لفاعليته في الجسم.</p><p dir="RTL" style="text-align:right">يستخدم جيڨي <strong>لعلاج ومنع النزيف</strong> في البالغين والمراهقين اعتباراً من 12 عاماً والذين كانوا يعالجون سابقاً لأنهم يعانون من الهيموفيليا أ (نزف الدم الوراثي - نقص وراثي في العامل الثامن لتجلط الدم). لا يستخدم للأطفال الذين تقل أعمارهم عن 12 عاماً.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>لا تستخدم </strong><strong>جيڨي</strong> إذا كنت تعاني من الآتي:</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->حساسية من داموكتوكوج ألفا بيجول أو أي من المكونات الأخرى لهذا الدواء (المذكورة في الجزء رقم 6).</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->حساسية لبروتينات الفأر أو الهامستر (حيوان قارض يشبه الفأر).</p><p dir="RTL" style="text-align:right"><strong>المحاذير والاحتياطات</strong></p><p dir="RTL" style="text-align:right"><strong>تحدث إلى طبيبك أو الصيدلي إذا كنت تعاني من </strong><strong>الآتي</strong><strong>:</strong></p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الإحساس بضيق في الصدر، هبوط في ضغط الدم (غالباً ما يظهر من خلال الشعور بالدوار عند الوقوف بسرعة)، بقع جلدية حمراء مرتفعة عن سطح الجلد مع حكة شديدة، سماع صوت صفير عند التنفس، الشعور بالغثيان أو الإغماء. قد تكون هذه علامات رد فعل <strong>لحساسية مفاجئة حادة</strong> نادرة لهذا الدواء. إذا حدث ذلك، <strong>توقف عن حقن المستحضر</strong> فوراً واحصل على مساعدة طبية في الحال.</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->نزيف لا يتم التحكم به باستخدام جرعتك المعتادة من هذا الدواء. إذا حدث ذلك تحدث مع طبيبك على الفور. ربما قد تم تكوين أجسام مضادة (مثبطات) ضد العامل الثامن أو أجسام مضادة ضد البولي إيثيلين جلايكول. هذه الحالة تجعل جيڨي أقل فعّالية في منع النزيف والسيطرة عليه. قد يقوم الطبيب بإجراء اختبارات للتأكد من ذلك والتأكد من أن جرعة جيڨي الخاصة بك توفر مستويات كافية من العامل الثامن. إذا لزم الأمر، قد يعيدك طبيبك إلى العلاج بالعامل الثامن السابق.</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تم تكوين مثبطات للعامل الثامن عندما كنت تستخدم مستحضر مختلف&nbsp; في السابق.</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تعاني حالياً من مرض في القلب أو لديك مخاطرة من الإصابة بمرض في القلب.</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->لديك صعوبة في وضع قسطرة في وريد كبير يستخدم لحقن هذا الدواء. قد تكون معرض لمخاطر حدوث مضاعفات متعلقة باستخدام القسطرة التي يتم إدخالها وهذه المضاعفات هي كما يلي:</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->عدوى موضعية</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بكتيريا في الدم</p><p dir="RTL" style="margin-left:0in; margin-right:.5in; text-align:right; text-indent:-.25in"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->جلطة دموية في الأوعية الدموية</p><p dir="RTL" style="text-align:right"><strong>الأطفال</strong></p><p dir="RTL" style="text-align:right">لا يستخدم جيڨي لدى الأطفال الذين تقل أعمارهم عن 12 سنة.</p><p dir="RTL" style="text-align:right"><strong>استخدام أدوية أخرى مع جيڨي</strong></p><p dir="RTL" style="text-align:right">لا يعرف عن جيڨي التأثير أو التأثر بالأدوية الأخرى. أخبر طبيبك أو الصيدلي إذا كنت تستخدم الآن، استخدمت حديثاً أو قد تستخدم أي أدوية أخرى.</p><p dir="RTL" style="text-align:right"><strong>استخدام جيڨي أثناء فترة الحمل وأثناء فترة القيام بالرضاعة الطبيعية</strong></p><p dir="RTL" style="text-align:right">إذا كنتِ حاملاً أو أثناء فترة القيام بالرضاعة الطبيعية، احتمال أنكِ قد تكونين حاملاً أو تخططين لإنجاب طفل، يجب طلب الحصول على المشورة من طبيبك قبل استخدام هذا الدواء.</p><p dir="RTL" style="text-align:right"><strong>قيادة السيارات واستخدام الآلات</strong></p><p dir="RTL" style="text-align:right">لا يوجد لجيڨي تأثير على قدرتك في قيادة السيارات واستخدام الآلات.</p><p dir="RTL" style="text-align:right"><strong>يحتوي جيڨي على الصوديوم</strong></p><p dir="RTL" style="text-align:right">يحتوي هذا الدواء على أقل من 1 ميليمول (23 ملليجرام) صوديوم لكل جرعة، وبالتالي هذا يعني في الواقع &quot;خالٍ من الصوديوم&quot;.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">يجب على المريض أن يبدأ باستخدام دواء جيڨي مع طبيب لديه الخبرة في رعاية المرضى الذين يعانون من الهيموفيليا أ (نزف الدم الوراثي - نقص وراثي في العامل الثامن لتجلط الدم). قد يتمكن المرضى أو مقدمي الرعاية من إعطاء جيڨي في المنزل، بعد التدريب المناسب. استخدم هذا الدواء دائماً كما هو موضح في هذه النشرة وكما أخبرك طبيبك أو الصيدلي. استشر طبيبك أو الصيدلي إذا كنت غير متأكد. يتم قياس جرعة وحدات العامل الثامن بالوحدات الدولية.</p><p dir="RTL" style="text-align:right"><strong>علاج النزيف</strong></p><p dir="RTL" style="text-align:right">لعلاج النزف، يقوم الطبيب بحساب الجرعة وضبطها وعدد المرات التي يجب إعطائها، حسب العوامل الآتية:</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->وزن المريض</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->شدة مرض الهيموفيليا أ (نزف الدم الوراثي - نقص وراثي في العامل الثامن لتجلط الدم) الخاص بالمريض.</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->أين يوجد النزيف ومدى خطورته</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->إذا كان لديك مثبطات (تكوين أجسام مضادة للعامل الثامن لتجلط الدم) ومدى ارتفاع مستواها</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مستوى العامل الثامن المطلوب في الدم.</p><p dir="RTL" style="text-align:right"><strong>منع النزيف</strong></p><p dir="RTL" style="text-align:right">سيحدد طبيبك حسب حاجتك الجرعة المناسبة وتكرارها لمنع النزيف:</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->45-60 وحدة دولية لكل كيلوجرام من وزن الجسم كل 5 أيام أو</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->60 وحدة دولية لكل كيلوجرام من وزن الجسم كل 7 أيام أو</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->30-40 وحدة دولية لكل كيلوجرام من وزن الجسم مرتين في الأسبوع.</p><p dir="RTL" style="text-align:right"><strong>اختبارات المعمل</strong></p><p dir="RTL" style="text-align:right">القيام باختبارات المعمل على فترات مناسبة تساعد على ضمان أن يكون لديك دائماً مستويات كافية من العامل الثامن. في العمليات الجراحية الكبرى على وجه الخصوص، يجب مراقبة تجلط الدم بدقة وحذر شديد.</p><p dir="RTL" style="text-align:right"><strong>مدة العلاج</strong></p><p dir="RTL" style="text-align:right">عادة ما تكون هناك حاجة إلى العلاج باستخدام جيڨي من أجل الهيموفيليا أ (نزف الدم الوراثي - نقص وراثي في العامل الثامن لتجلط الدم) لمدى الحياة.</p><p dir="RTL" style="text-align:right"><strong>كيف يتم إعطاء جيڨي</strong></p><p dir="RTL" style="text-align:right">يتم حقن جيڨي في الوريد خلال 2 إلى 5 دقائق اعتماداً على الحجم الكلي المطلوب حقنه ومستوى راحة المريض. الحد الأقصى لمعدل الحقن هو 2.5 ملليلتر في الدقيقة. يجب استخدام جيڨي في غضون 3 ساعات بعد إعادة التركيب (إذابة مسحوق الدواء باستخدام مذيب للحصول على محلول الحقن).</p><p dir="RTL" style="text-align:right"><strong>كيف يتم إعداد جيڨي للحقن</strong></p><p dir="RTL" style="text-align:right">استخدم فقط المكونات الموجودة مع كل عبوة من هذا الدواء (وصلة مهيأة للقارورة (فايل)، محقنة مملوءة مسبقاً والتي تحتوي على مذيب ومجموعة ثقب الوريد). يرجى الاتصال بالطبيب إذا كان لا يمكن استخدام هذه المكونات. لا تستخدم أي مكون من هذه المكونات إذا كانت مفتوحة أو تالفة.</p><p dir="RTL" style="text-align:right">يجب <strong>ترشيح المنتج المعاد تركيبه</strong> (إذابة مسحوق الدواء باستخدام مذيب للحصول على محلول الحقن) <strong>باستخدام الوصلة المهيأة للقارورة</strong> قبل الحقن لإزالة أي جسيمات ممكنة في المحلول.</p><p dir="RTL" style="text-align:right">يجب <strong>ألا</strong> يخلط هذا الدواء مع الحقن الأخرى. لا تستخدم المحاليل الغائمة (غير صافية - ليست شفافة) أو التي تحتوي على جسيمات مرئية. اتبع <strong>تعليمات الاستخدام</strong> التي يقدمها طبيبك والتي تم تقديمها في <strong>نهاية هذه النشرة.</strong></p><p dir="RTL" style="text-align:right"><strong>إذا استخدمت كمية من مستحضر جيڨي أكثر مما ينبغي</strong></p><p dir="RTL" style="text-align:right">أخبر طبيبك إذا حدث هذا. لم يتم الإبلاغ عن أي أعراض ناتجة من الجرعة الزائدة.</p><p dir="RTL" style="text-align:right"><strong>إذا نسيت استخدام جيڨي</strong></p><p dir="RTL" style="text-align:right">يجب القيام بحقن الجرعة التالية على الفور واستمر في استخدام المستحضر على فترات منتظمة حسب إرشادات الطبيب. لا تستخدم جرعة مضاعفة للتعويض عن جرعة منسية.</p><p dir="RTL" style="text-align:right"><strong>إذا توقفت عن استخدام جيڨي</strong></p><p dir="RTL" style="text-align:right">لا تتوقف عن استخدام هذا الدواء بدون مراجعة الطبيب.</p><p dir="RTL" style="text-align:right">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">---------------------------------------------------------------------------------------------------------------------------------------------------------------</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right"><strong>تعليمات مفصلة لإعادة تركيب جيڨي (إذابة مسحوق الدواء باستخدام </strong><strong>مذيب للحصول على محلول الحقن)</strong><strong> وطريقة حقنه في الوريد.</strong></p><p dir="RTL" style="text-align:right">سوف تحتاج لقطع ماصة مبللة بالكحول، قطع من الشاش الطبي، شرائط طبية لاصقة وعاصِبَة (أداة للضغط على الأوعية الدموية للمساعدة على الحقن في الوريد). لا تحتوي عبوة جيڨي على هذه المكونات.</p><table dir="rtl" cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">1-</p></td><td colspan="2" style="border-color:black; vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">اغسل يديك جيداً باستخدام الصابون والماء الدافئ.</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">2-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">امسك قارورة (فايل) غير مفتوحة وأيضاً محقنة في يديك لتدفئتهم إلى درجة حرارة ملائمة (لا تتجاوز 37 درجة مئوية).</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">3-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">قم بإزالة الغطاء الواقي من على القارورة (فايل) (<strong>A</strong>). يجب مسح السدادة المطاطية للقارورة (فايل) باستخدام قطعة ماصة &nbsp;مبللة بالكحول والسماح للسدادة المطاطية أن تجف في الهواء قبل الاستخدام.</p><p dir="RTL" style="text-align:right">&nbsp;</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">4-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">ضع <strong>قارورة</strong> (فايل) <strong>المستحضر</strong> التي بداخلها المسحوق على سطح ثابت غير قابل للانزلاق. قم بإزالة غطاء الورق الموجود على الغلاف البلاستيك للوصلة المهيأة للقارورة (فايل). <strong>يجب عدم إزالة</strong> الغلاف البلاستيك من على الوصلة المهيأة للقارورة (فايل). امسك الغلاف البلاستيك للوصلة المهيأة للقارورة (فايل)، ضعه على قارورة (فايل) المستحضر التي بداخلها المسحوق واضغط بقوة لأسفل (<strong>B</strong>). نتيجةً لذلك، سوف تستقر وتثبت الوصلة المهيأة للقارورة (فايل) على غطاء القارورة (فايل). <strong>يجب عدم إزالة</strong> الغلاف البلاستيك للوصلة المهيأة للقارورة (فايل) في هذه المرحلة.</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; height:72.1pt; vertical-align:top"><p dir="RTL" style="text-align:right">5-</p></td><td style="height:72.1pt; vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">امسك المحقنة المملوءة مسبقاً والتي تحتوي على مذيب في وضع مستقيم. امسك قضيب المكبس كما هو واضح في الرسم المبسط، ثم يجب توصيل قضيب المكبس بالمحقنة عن طريق دوران قضيب المكبس بحزم باتجاه عقارب الساعة في سدادة المحقنة المسننة من الداخل (<strong>C</strong>).</p></td><td style="height:72.1pt; vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">6-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">امسك المحقنة من الأنبوب الاسطواني، انزع غطاء المحقنة لفصل الغطاء عن قمة المحقنة (<strong>D</strong>). لا تلامس طرف المحقنة بيدك أو بأي سطح. ضع المحقنة جانباً لمزيد من الاستخدام.</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">7-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">الآن يتم إزالة والتخلص من الغلاف البلاستيك للوصلة المهيأة للقارورة (فايل) (<strong>E</strong>).</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">8-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">يجب توصيل المحقنة المعبأة مسبقاً إلى الوصلة المهيأة للقارورة (فايل) المسننة من الداخل عن طريق الدوران باتجاه عقارب الساعة (<strong>F</strong>).</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">9-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">يتم حقن المذيب عن طريق الضغط ببطء بالدفع إلى أسفل على قضيب المكبس (<strong>G</strong>).</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">10-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">يتم تحريك القارورة (فايل) بلطف مع حركة ملتوية أو دوران حتى يتم إذابة المسحوق بالكامل (<strong>H</strong>). يجب عدم رجّ القارورة (فايل). تأكد من أن المسحوق مذاب بالكامل. قبل استخدام المحلول انظر إليه، للتأكد من عدم وجود جزيئات أو تغير اللون. لا تستخدم المحاليل التي تحتوي على جسيمات مرئية أو المحاليل الغائمة (غير صافية - ليست شفافة).</p><p dir="RTL" style="text-align:right">&nbsp;</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">11-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">امسك القارورة (فايل) بطريقة تجعل فيها السطح السفلي لها فوق الوصلة المهيأة للقارورة (فايل) والمحقنة (<strong>I</strong>). تُملأ المحقنة، بسحب المكبس ببطء وبدون شدة (بلطف). تأكد من أن المحلول داخل القارورة (فايل) قد تم سحبه إلى المحقنة بالكامل. امسك المحقنة في وضع مستقيم وادفع المكبس حتى لا يتم ترك أي هواء في المحقنة.</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">12-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">استخدم العاصِبَة (أداة للضغط على الأوعية الدموية للمساعدة على الحقن في الوريد) على ذراعك.</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">13-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">يتم تحديد مكان الحقن وتنظيف الجلد.</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">14-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">يتم ثقب الوريد وحماية مجموعة ثقب الوريد باستخدام شريط طبي لاصق.</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">15-</p></td><td style="vertical-align:top; width:376.9pt"><p dir="RTL" style="text-align:right">امسك الوصلة المهيأة للقارورة (فايل) في مكانها، انزع المحقنة من الوصلة المهيأة للقارورة (فايل) (يجب أن تظل الوصلة المهيأة للقارورة (فايل) متصلة بالقارورة). يتم توصيل المحقنة بمجموعة ثقب الوريد (<strong>J</strong>). تأكد من عدم دخول الدم إلى المحقنة</p><p dir="RTL" style="text-align:right">&nbsp;</p></td><td style="vertical-align:top; width:90.05pt"><p dir="RTL" style="text-align:center"><img src="data:image/png;base64,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" /></p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">16-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">يتم إزالة العاصِبَة (أداة للضغط على الأوعية الدموية للمساعدة على الحقن في الوريد).</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">17-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">احقن المحلول في الوريد على مدى 2 إلى 5 دقائق، مع الانتباه بشأن وضع الإبرة خلال الحقن. يجب أن تعتمد سرعة الحقن على إحساسك بالراحة أثناء الحقن، ولكن يجب ألا تكون أسرع من 2.5 ملليلتر في الدقيقة.</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">18-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">إذا كانت هناك حاجة إلى جرعة إضافية، استخدم محقنة جديدة مع إعادة التركيب (إذابة مسحوق الدواء باستخدام مذيب للحصول على محلول الحقن) للمستحضر كما هو موضح أعلاه.</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">19-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">إذا لم يكن هناك حاجة إلى جرعة إضافية، في هذه الحالة يتم إزالة مجموعة ثقب الوريد والمحقنة. ضع قطعة من الشاش الطبي فوق مكان الحقن على ذراعك الممدود لمدة دقيقتين تقريباً. أخيراً، ضع رباط طبي ضاغط صغير على مكان الحقن ويؤخذ بعين الاعتبار ما إذا كان هناك ضرورة لاستخدام شريط طبي لاصق.</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">20-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right">يوصى بتدوين اسم ورقم تشغيلة المستحضر في كل مرة يتم فيها استخدام جيڨي.</p></td></tr><tr><td style="border-color:black; vertical-align:top"><p dir="RTL" style="text-align:right">21-</p></td><td colspan="2" style="vertical-align:top; width:466.95pt"><p dir="RTL" style="text-align:right"><strong>لا</strong> تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو عن طريق النفايات المنزلية. اسأل الصيدلي أو الطبيب عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. سوف تساعد هذه التدابير في حماية البيئة.</p></td></tr></tbody></table><p dir="RTL" style="text-align:right">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">مثل جميع الأدوية، يمكن أن يسبب هذا الدواء آثار جانبية، على الرغم من أنها لا تحدث للجميع.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">الآثار الجانبية الأكثر خطورة هي <strong>تفاعلات حساسية</strong> أو تفاعل حساسية شديد. <strong>إذا حدثت مثل هذه التفاعلات،</strong> <strong>يجب التوقف عن حقن </strong><strong>جيڨي</strong><strong> على الفور والتحدث حالاً مع طبيبك</strong>. يمكن أن تكون الأعراض التالية إنذاراً مبكراً لهذه التفاعلات:</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ضيق في الصدر / الشعور العام بأنك ليس على ما يرام.</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الإحساس بحرق ولسع في مكان الحقن</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->بقع جلدية حمراء مرتفعة عن سطح الجلد مع حكة شديدة، احمرار الوجه والعنق</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->انخفاض في ضغط الدم، مما قد يجعلك تشعر بالإغماء عند الوقوف</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الشعور بالغثيان (الغثيان)</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">بالنسبة للمرضى الذين تلقوا علاجاً سابقاً باستخدام العامل الثامن (أكثر من 150 يوماً من العلاج)، قد تتكون الأجسام المضادة المثبطة (انظر الجزء رقم 2)، وتكرار حدوث ذلك غير شائع (أقل من 1 من كل 100 مريض). إذا حدث هذا قد يتوقف الدواء عن العمل بشكل صحيح وقد تعاني من نزيف مستمر. إذا حدث هذا، يجب عليك الاتصال بطبيبك فوراً.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">قد تحدث مع هذا الدواء الآثار الجانبية التالية:</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right"><strong>شائع جداً</strong> (قد يحدث لدى أكثر من 1 من كل 10 أشخاص):</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->صداع</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right"><strong>شائع </strong>(قد يحدث لدى 1 من كل 10 أشخاص):</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->ألم المعدة</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الغثيان، القيء</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->حُمًّى (ارتفاع درجة حرارة الجسم)</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تفاعلات حساسية (قد تظهر على شكل فقاعات و بثور حمراء كبيرة تظهر على الجلد، بقع جلدية تغطي الجسم كله حمراء اللون مرتفعة عن سطح الجلد شديدة الحكة، ضيق في الصدر، صفير عند التنفس، ضيق في التنفس، انخفاض في ضغط الدم، للأعراض المبكرة انظر أعلاه)</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->تفاعلات موضعية في مكان الحقن مثل نزيف تحت الجلد، حكة شديدة، تورم، الإحساس بحرق، الاحمرار المؤقت</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->دوخة</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الأرَق (اضطراب في النوم أو تقطعه أو انخفاض جودته)</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->سعال</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->الطفح الجلدي (منطقة من الجلد مصابة بالاحمرار أو بقع تظهر على الجلد)، احمرار الجلد</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right"><strong>غير شائع</strong> (قد يحدث لدى شخص واحد من كل 100 شخص):</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->اضطراب حاسة التذوق</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->احمرار الوجه والعنق</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->حكة الجلد</p><p dir="RTL" style="text-align:right"><strong>&nbsp;</strong></p><p dir="RTL" style="text-align:right"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL" style="text-align:right">إذا تم إصابتك بأي آثار جانبية، تحدث مع طبيبك. يتضمن ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة. من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة في تقديم مزيد من المعلومات عن سلامة وأمان هذا الدواء.</p><p dir="RTL" style="text-align:right"><strong>للإبلاغ عن أي آثار جانبية:</strong></p><p dir="RTL" style="text-align:right">المملكة العربية السعودية</p><p dir="RTL">المركز الوطني للتيقظ الدوائي</p><p dir="RTL">فاكس: 7662 &ndash; 205 &ndash; 11 &ndash; 966 +</p><p dir="RTL">مركز اتصال الهيئة العامة للغذاء والدواء: 19999</p><p dir="RTL">البريد الالكتروني:&nbsp;npc.drug@sfda.gov.sa&nbsp;</p><p dir="RTL" style="text-align:right">الموقع الالكتروني:&nbsp;https://ade.sfda.gov.sa</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">احتفظ بهذا الدواء بعيداً عن أعين ومتناول أيدي الأطفال.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right"><strong>لا</strong> تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المكتوب علي بطاقة المستحضر الملصقة وعلى العلبة الكرتون. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">يتم تخزين المستحضر في الثلاجة (البَرَّاد) (2 درجة مئوية - 8 درجة مئوية). يجب عدم تجميد المستحضر.</p><p dir="RTL" style="text-align:right">حافظ على الدواء في عبوته الأصلية من أجل الحماية من الضوء.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">يمكن تخزين هذا الدواء في درجة حرارة الغرفة (حتى 25 درجة مئوية) لمدة تصل إلى 6 أشهر وذلك عندما تحتفظ بالمستحضر داخل العلبة الكرتونية الخارجية. إذا تم تخزين المستحضر في درجة حرارة الغرفة فإن صلاحية المستحضر تنتهي بعد 6 أشهر، أو عند تاريخ انتهاء الصلاحية المكتوب على العلبة إذا كان هذا التاريخ قبل ذلك.</p><p dir="RTL" style="text-align:right">يجب كتابة تاريخ انتهاء الصلاحية الجديد على الكرتون الخارجي للعبوة المستحضر عند إخراج الدواء من الثلاجة (البَرَّاد).</p><p dir="RTL" style="text-align:right"><strong>يجب عدم</strong> إعادة المستحضر إلى الثلاجة (البَرَّاد) بعد إعادة التركيب (إذابة مسحوق الدواء باستخدام مذيب للحصول على محلول الحقن). يجب استخدام محلول المستحضر بعد إعادة التركيب (إذابة مسحوق الدواء باستخدام مذيب للحصول على محلول الحقن) خلال 3 ساعات.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right"><strong>لا </strong>تستخدم هذا الدواء إذا لاحظت أن المحلول يحتوي على جسيمات مرئية أو أن المحلول غائم (غير صافي - ليس شفاف)</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">هذا الدواء هو للاستخدام مرة واحدة فقط. يجب التخلص من أي محلول غير مستخدم.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right"><strong>لا</strong> تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو عن طريق النفايات المنزلية. اسأل الصيدلي أو الطبيب عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. سوف تساعد هذه التدابير في حماية البيئة.</p><p dir="RTL" style="text-align:right">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>المادة الفعالة</strong> هي وحدات متكررة من البولي إيثيلين جلايكول مرطبة كيمائياً مع بعضها ومدمجة بجزيئات العامل الثامن البشري لتجلط الدم المصَنّع عن طريق إعادة تركيب المادة النووية وتم حذف من هذه الجزيئات الجزئية ب (داموكتوكوج ألفا بيجول) تحتوي كل قارورة (فايل) جيڨي على 500 أو 1000 أو 2000 وحدة دولية اسمياً من داموكتوكوج ألفا بيجول.</p><p dir="RTL" style="text-align:right"><strong>المكونات الأخرى</strong> هي السكروز، الهيستدين، الجلايسين، كلوريد الصوديوم، كلوريد الكالسيوم ثنائي الهيدرات، بولي سوربات 80، حمض الخليك الجليدي (حمض الخل النقي والخالي من الماء) وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">جيڨي متوفر كمسحوق ومذيب للحصول على محلول للحقن. المسحوق جاف، ولونه أبيض إلى أصفر قليلاً.المذيب سائل صافي (شفاف). بعد إعادة التركيب (إذابة مسحوق الدواء باستخدام مذيب للحصول على محلول الحقن) المحلول صافي (شفاف).</p><p dir="RTL" style="text-align:right">كل عبوة جيڨي تحتوي على</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->قارورة (فايل) من الزجاج بها مسحوق</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->محقنة مملوءة مسبقاً تحتوي على مذيب</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->قضيب مكبس منفصل</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->وصلة مهيأة للقارورة (فايل)</p><p dir="RTL" style="margin-left:0in; margin-right:14.6pt; text-align:right; text-indent:-14.15pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->مجموعة ثقب الوريد</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>المصنّع:</strong></p><p dir="RTL" style="text-align:right">باير هلثكير ال ال سي،</p><p dir="RTL" style="text-align:right">بيركلي، الولايات المتحدة الأمريكية.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right"><strong>يتم الإفراج النهائي عن المستحضر من:</strong></p><p dir="RTL" style="text-align:right">باير ايه جي</p><p dir="RTL" style="text-align:right">51368 ليفركوزن، ألمانيا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            11/2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jivi 250 IU powder and solvent for solution for injection
Jivi 500 IU powder and solvent for solution for injection
Jivi 1000 IU powder and solvent for solution for injection
Jivi 2000 IU powder and solvent for solution for injection
Jivi 3000 IU powder and solvent for solution for injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jivi 250 IU powder and solvent for solution for injection
After reconstitution with the solvent provided, one mL of solution contains approximately 100 IU (250 IU/2.5 mL) of human coagulation factor VIII, damoctocog alfa pegol.

Jivi 500 IU powder and solvent for solution for injection
After reconstitution with the solvent provided, one mL of solution contains approximately 200 IU (500 IU/2.5 mL) of human coagulation factor VIII, damoctocog alfa pegol.

Jivi 1000 IU powder and solvent for solution for injection
After reconstitution with the solvent provided, one mL of solution contains approximately 400 IU (1000 IU/2.5 mL) of human coagulation factor VIII, damoctocog alfa pegol.

Jivi 2000 IU powder and solvent for solution for injection
After reconstitution with the solvent provided, one mL of solution contains approximately 800 IU (2000 IU/2.5 mL) of human coagulation factor VIII, damoctocog alfa pegol.

Jivi 3000 IU powder and solvent for solution for injection
After reconstitution with the solvent provided, one mL of solution contains approximately 1200 IU (3000 IU/2.5 mL) of human coagulation factor VIII, damoctocog alfa pegol.

The potency International Unit (IU) is determined using the European Pharmacopoeia chromogenic assay.
The specific activity of Jivi is approximately 10000 IU/mg protein.

The active substance, damoctocog alfa pegol, is a site specifically PEGylated B-domain deleted recombinant human coagulation factor VIII, produced in baby hamster kidney cells (BHK), with a 60 kDa branched polyethylene-glycol (two 30 kDa PEG) moiety. The molecular weight of the protein is approximately 234 kDa.

Jivi is produced without the addition of any human or animal derived protein in the cell culture process, purification, PEGylation or final formulation.

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder and solvent for solution for injection.

Powder: solid, white to slightly yellow.
Solvent: clear solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment and prophylaxis of bleeding in previously treated patients &ge;&nbsp;12&nbsp;years of age with haemophilia&nbsp;A (congenital factor&nbsp;VIII deficiency).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment should be under the supervision of a physician experienced in the treatment of haemophilia.</p><p><u>Treatment monitoring</u></p><p>&nbsp;</p><p style="margin-right:-1.0pt">During the course of treatment, appropriate determination of factor&nbsp;VIII levels is advised to confirm that adequate FVIII levels have been achieved. Individual patients may vary in their response to factor&nbsp;VIII, demonstrating different half-lives and recoveries. Dose based on bodyweight may require adjustment in overweight patients. In the case of major surgical interventions in particular, precise monitoring of the substitution therapy by means of coagulation analysis (plasma factor&nbsp;VIII activity) is indispensable.</p><p>&nbsp;</p><p>When using an <em>in</em>&nbsp;<em>vitro</em> activated partial thromboplastin time (aPTT)-based one stage clotting assay for determining factor&nbsp;VIII activity in patients&rsquo; blood samples, plasma factor&nbsp;VIII activity results can be significantly affected by both the type of aPTT reagent and the reference standard used in the assay, which can result in over- or under-estimation of factor&nbsp;VIII activity. It should be noted that there can be significant discrepancies between assay results obtained by specific reagents used in the aPTT-based one stage clotting assay and the chromogenic assay. This is of importance when monitoring the factor&nbsp;VIII activity of Jivi, and when changing laboratory and/or reagents used in the assay. This applies also for modified long acting factor&nbsp;VIII products.</p><p>Laboratories intending to measure Jivi activity should check their procedures for accuracy. A field study has indicated that the factor&nbsp;VIII activity of Jivi can be accurately measured in plasma using either a validated chromogenic substrate (CS) assay or a one-stage (OS) clotting assay using specific reagents. For Jivi some silica-based one-stage assays (e.g., APTT-SP, STA-PTT) may underestimate the factor&nbsp;VIII activity of Jivi in plasma samples; some reagents, e.g. with kaolin-based activators, have the potential for overestimation.</p><p>&nbsp;</p><p>The clinical effect of&nbsp;factor&nbsp;VIII is the most important element in evaluating the effectiveness of treatment. It may be necessary to adjust the individual dosing at patient level in order to attain satisfactory clinical results. If the calculated dose fails to attain the expected factor&nbsp;VIII levels or if bleeding is not controlled after administration of the calculated dosage, the presence of a circulating factor&nbsp;VIII-inhibitor or anti-PEG antibodies in the patient should be suspected (see section&nbsp;4.4).</p><p>&nbsp;</p><p><u>Posology</u></p><p>&nbsp;</p><p>The dose and duration of substitution therapy depends on the severity of the factor&nbsp;VIII deficiency, the location and extent of the bleeding and on the patient&#39;s clinical condition.</p><p>The number of units of factor&nbsp;VIII administered is expressed in International Units (IU), which are related to the current WHO concentrate standard for factor&nbsp;VIII products. Factor&nbsp;VIII activity in plasma is expressed either as a percentage (relative to normal human plasma) or preferably in IU (relative to an International Standard for factor&nbsp;VIII in plasma).</p><p>&nbsp;</p><p style="margin-left:0in; margin-right:0in">One IU of factor&nbsp;VIII activity is equivalent to that quantity of factor&nbsp;VIII in one&nbsp;mL of normal human plasma.</p><p>&nbsp;</p><p><em>On demand treatment</em></p><p>&nbsp;</p><p>The calculation of the required dose of factor&nbsp;VIII is based on the empirical finding that 1&nbsp;IU factor&nbsp;VIII per kg body weight raises the plasma factor&nbsp;VIII activity by 1.5-2.5&nbsp;%&nbsp;of&nbsp;normal&nbsp;activity.</p><p>The required dose of Jivi is determined using the following formula:</p><p>&nbsp;</p><p>Required units = body weight (kg) x desired factor&nbsp;VIII rise (% or&nbsp;IU/dL) x reciprocal of observed recovery (i.e. 0.5 for recovery of 2.0%).</p><p>&nbsp;</p><p>The amount to be administered and the frequency of administration should always be oriented to the clinical effectiveness required in the individual case.</p><p>&nbsp;</p><p>In the case of the following haemorrhagic events, the factor&nbsp;VIII activity should not fall below the given plasma activity level (in % of normal) in the corresponding period. The following table can be used to guide dosing in bleeding episodes and surgery:</p><p>&nbsp;</p><p>Table <!--[if supportFields]><span lang=EN-GB
style='font-size:11.0pt'><span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>SEQ Table \* ARABIC <span style='mso-element:
field-separator'></span></span><![endif]-->1<!--[if supportFields]><span
lang=EN-GB style='font-size:11.0pt;mso-no-proof:yes'><span style='mso-element:
field-end'></span></span><![endif]-->: Guide for dosing in bleeding episodes and surgery for adolescents and adults</p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1" style="width:605px"><tbody><tr><td style="border-color:black; vertical-align:top; width:148.85pt"><p>Degree of haemorrhage/Type of surgical procedure</p><p>&nbsp;</p></td><td style="vertical-align:top; width:92.15pt"><p>Factor&nbsp;VIII level required (%) (IU/dL)</p></td><td style="border-color:black; vertical-align:top; width:212.6pt"><p>Frequency of doses (hours) / Duration of therapy (days)</p></td></tr><tr><td style="vertical-align:top; width:148.85pt"><p><u>Haemorrhage</u></p><p>&nbsp;</p><p>Early haemarthrosis, muscle</p><p style="margin-left:0in; margin-right:0in">bleeding or oral bleeding</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p></td><td style="width:92.15pt"><p style="margin-left:0in; margin-right:0in">20-40</p></td><td style="vertical-align:top; width:212.6pt"><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">Repeat injection every 24-48&nbsp;hours.</p><p style="margin-left:0in; margin-right:0in">At least 1&nbsp;day, until bleeding episode as indicated by pain is resolved or healing is achieved<br /><!--[if !supportLineBreakNewLine]--><br /><!--[endif]--></p></td></tr><tr><td style="vertical-align:top; width:148.85pt"><p>More extensive</p><p>haemarthrosis, muscle</p><p style="margin-left:0in; margin-right:0in">bleeding or haematoma<br /><!--[if !supportLineBreakNewLine]--><br /><!--[endif]--></p></td><td style="width:92.15pt"><p style="margin-left:0in; margin-right:0in">30-60</p></td><td style="vertical-align:top; width:212.6pt"><p style="margin-left:0in; margin-right:0in">Repeat injection every 24-48&nbsp;hours for 3&nbsp;to&nbsp;4&nbsp;days or more until pain and acute disability are resolved.</p></td></tr><tr><td style="vertical-align:top; width:148.85pt"><p style="margin-left:0in; margin-right:0in"><u>Life-threatening</u></p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">Haemorrhages</p><p style="margin-left:0in; margin-right:0in"><strong>&nbsp;</strong></p></td><td style="width:92.15pt"><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">60-100</p></td><td style="vertical-align:top; width:212.6pt"><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">Repeat injection every 8&nbsp;to&nbsp;24&nbsp;hours until threat is resolved.</p></td></tr><tr><td style="vertical-align:top; width:148.85pt"><p><u>Surgery</u></p><p>&nbsp;</p><p>Minor surgery</p><p style="margin-left:0in; margin-right:0in">including tooth extraction</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p></td><td style="width:92.15pt"><p style="margin-left:0in; margin-right:0in">30-60</p></td><td style="vertical-align:top; width:212.6pt"><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">Every 24&nbsp;hours, at least 1&nbsp;day, until healing is achieved.</p></td></tr><tr><td style="height:69.9pt; vertical-align:top; width:148.85pt"><p><u>Major surgery</u></p><p>&nbsp;</p></td><td style="height:69.9pt; width:92.15pt"><p style="margin-left:0in; margin-right:0in">80-100 (pre- and post-operative)</p></td><td style="height:69.9pt; vertical-align:top; width:212.6pt"><p style="margin-left:0in; margin-right:0in">Repeat dose every</p><p style="margin-left:0in; margin-right:0in">12-24&nbsp;hours until adequate wound healing, then therapy for at least another 7&nbsp;days to maintain factor VIII activity of 30-60% (IU/dL).</p></td></tr></tbody></table><p><u>&nbsp;</u></p><p style="margin-left:0in; margin-right:0in; text-align:left"><em>Prophylaxis</em></p><p style="margin-left:0in; margin-right:0in; text-align:left">&nbsp;</p><p>All treatment decisions for identifying appropriate prophylactic treatment regimens should be guided by clinical judgement based on individual patient characteristics and treatment response.</p><p>&nbsp;</p><p style="margin-left:0in; margin-right:0in">For prophylaxis the dose is 45-60&nbsp;IU/kg every 5&nbsp;days. Based on patient clinical characteristics the dose can also be 60&nbsp;IU/kg every 7&nbsp;days or 30-40&nbsp;IU/kg two&nbsp;times per week (see sections&nbsp;5.1 and&nbsp;5.2).</p><p>&nbsp;</p><p style="margin-left:0in; margin-right:0in">For overweight patients, the maximum dose per injection for prophylaxis should not be higher than approximately 6000&nbsp;IU.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p style="margin-left:0in; margin-right:0in; text-align:left">Jivi is not indicated in previously untreated patients and in patients less than 12&nbsp;years of age.</p><p>&nbsp;</p><p><em>Adolescent population</em></p><p>On demand and prophylactic treatment dosing in adolescent patients is the same as for adult patients.</p><p>&nbsp;</p><p><em>Elderly population</em></p><p style="margin-left:0in; margin-right:0in">There is limited experience in patients &ge; 65&nbsp;years.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>Jivi is for intravenous use.</p><p>&nbsp;</p><p>Jivi should be injected intravenously over a period of 2&nbsp;to&nbsp;5&nbsp;minutes depending on the total volume. The rate of administration should be determined by the patient&rsquo;s comfort level (maximal rate of injection: 2.5&nbsp;mL/min).</p><p>&nbsp;</p><p>For instructions on reconstitution of the medicinal product before administration, see section&nbsp;6.6 and the package leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Known allergic reactions to mouse or hamster proteins.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Traceability</u></p><p>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p><p><u>Hypersensitivity</u></p><p>&nbsp;</p><p style="margin-left:0in; margin-right:0in">Allergic type hypersensitivity reactions are possible with Jivi. The medicinal product may contain traces of mouse and hamster proteins. Hypersensitivity reactions could also be related to antibodies against PEG (see paragraph Immune response to polyethylene glycol (PEG)). If symptoms of hypersensitivity occur, patients should be advised to discontinue the use of the medicinal product immediately and contact their physician. Patients should be informed of the early signs of hypersensitivity reactions including hives, generalized urticaria, tightness of the chest, wheezing, hypotension, and anaphylaxis. Symptomatic treatment for hypersensitivity should be instituted as appropriate. In case of anaphylaxis or shock, the current medical standards for treatment should be implemented.</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p><u>Inhibitors</u></p><p>&nbsp;</p><p>The formation of neutralising antibodies (inhibitors) to factor&nbsp;VIII is a known complication in the management of individuals with haemophilia&nbsp;A. These inhibitors are usually IgG immunoglobulins directed against the factor&nbsp;VIII procoagulant activity, which are quantified in Bethesda Units (BU) per&nbsp;mL of plasma using the modified Bethesda assay. The risk of developing inhibitors is correlated to the severity of the disease as well as the exposure to factor&nbsp;VIII, this risk being highest within the first 50&nbsp;exposure&nbsp;days (ED) but continues throughout life although the risk is uncommon. Rarely, inhibitors may develop after the first 50&nbsp;exposure&nbsp;days.</p><p>&nbsp;</p><p>The clinical relevance of inhibitor development will depend on the titre of the inhibitor, with low titre posing less of a risk of insufficient clinical response than high titre inhibitors.</p><p>&nbsp;</p><p>In general, all patients treated with coagulation factor&nbsp;VIII products should be carefully monitored for the development of inhibitors by appropriate clinical observations and laboratory tests.</p><p>&nbsp;</p><p>If the expected factor&nbsp;VIII activity plasma levels are not attained, or if bleeding is not controlled with an appropriate dose, testing for factor&nbsp;VIII inhibitor presence should be performed. In patients with high levels of inhibitor, factor&nbsp;VIII therapy may not be effective and other therapeutic options should be considered. Management of such patients should be directed by physicians with experience in the care of haemophilia and factor&nbsp;VIII inhibitors.</p><p>&nbsp;</p><p><u>Immune response to polyethylene glycol (PEG)</u></p><p>&nbsp;</p><p>A clinical immune response associated with anti-PEG antibodies, manifested as symptoms of acute hypersensitivity and/or loss of drug effect has been observed primarily within the first 4 exposure days. Low post-injection factor&nbsp;VIII levels in the absence of detectable factor&nbsp;VIII inhibitors indicate that loss of drug effect is likely due to anti-PEG antibodies; in such cases Jivi should be discontinued and patients switched to a previously effective factor&nbsp;VIII product.</p><p>&nbsp;</p><p>A significant decrease in the risk of an immune response to PEG was observed with an increase in age. This effect may be related to a developmental change in immunity, and although it is difficult to define a clear cut-off age for the change in risk, this phenomenon predominantly occurs in young children with haemophilia.</p><p>&nbsp;</p><p>The implications of any potential risk to affected patients with a hypersensitivity reaction to pegylated proteins are unknown. Data show that in the affected subjects, following discontinuation of Jivi, the anti-PEG IgM antibodies decreased in titre and became undetectable over time . No cross-reactivity of anti-PEG IgM antibodies with other unmodified factor&nbsp;VIII products was observed. All patients could be successfully treated with their previous factor&nbsp;VIII products.</p><p>&nbsp;</p><p><u>Cardiovascular events</u></p><p>&nbsp;</p><p>In patients with existing cardiovascular risk factors, substitution therapy with factor&nbsp;VIII may increase the cardiovascular risk.</p><p>&nbsp;</p><p><u>Catheter-related complications</u></p><p>&nbsp;</p><p>If a central venous access device (CVAD) is required, risk of CVAD-related complications including local infections, bacteraemia and catheter site thrombosis should be considered.</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>&nbsp;</p><p>The listed warnings and precautions apply both to adults and adolescents.</p><p>Jivi is not indicated in patients &lt;&nbsp;12&nbsp;years of age and in previously untreated patients.</p><p>&nbsp;</p><p><u>Sodium content</u></p><p><u>&nbsp;</u></p><p>This medicinal product contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Interactions of human coagulation factor&nbsp;VIII (rDNA) products with other medicinal products have not been reported.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy and breast-feeding</u></p><p><u>&nbsp;</u></p><p>Animal reproduction studies have not been conducted with factor&nbsp;VIII. Based on the rare occurrence of haemophilia&nbsp;A in women, experience regarding the use of factor&nbsp;VIII during pregnancy and breast-feeding is not available. Therefore, factor&nbsp;VIII should be used during pregnancy and breast-feeding only if clearly indicated.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>&nbsp;</p><p style="margin-left:0in; margin-right:0in">In the repeat dose systemic toxicity studies in rats and rabbits with Jivi, treatment related effects on male reproductive organs were not seen (see section&nbsp;5.3). The effect on fertility in humans is unknown.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Jivi has no influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile</u></p><p>&nbsp;</p><p>Hypersensitivity or allergic reactions (which may include angioedema, burning and stinging at the injection site, chills, flushing, generalized urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed and may in some cases progress to severe anaphylaxis (including shock).</p><p>&nbsp;</p><p>Development of neutralising antibodies (inhibitors) may occur in patients with haemophilia&nbsp;A treated with factor&nbsp;VIII, including with Jivi (see section&nbsp;5.1). If such inhibitors occur, the condition will manifest itself as an insufficient clinical response. In such cases, it is recommended that a specialized haemophilia centre be contacted.</p><p>&nbsp;</p><p>The most frequently reported adverse reactions in clinical trials in PTPs were headache, cough and pyrexia.</p><p>&nbsp;</p><p><u>Tabulated list of adverse reactions</u></p><p>&nbsp;</p><p>A total of 221&nbsp;patients constituted the safety population from three pivotal Phase&nbsp;I&nbsp;and&nbsp;III&nbsp;studies [PROTECT&nbsp;VIII], 148&nbsp;adolescents/adults and 73&nbsp;paediatric patients &lt;&nbsp;12&nbsp;years. In PROTECT&nbsp;VIII, 121&nbsp;patients continued in the extension study with a median total treatment duration of 3.9&nbsp;years [range: 0.8-7.0].</p><p>In the paediatric study, 59/73&nbsp;patients &lt;&nbsp;12&nbsp;years continued in the extension study. Median (range) total time in study (main study + extension) was 5.8 (1.0-6.6) years with a median of 430 (range 98-671) ED per subject, 39&nbsp;subjects were treated for =/&gt;&nbsp;5&nbsp;years.</p><p>The median number of exposure days to Jivi per subject was 237 (min-max: 1-698) for all subjects in the clinical studies.</p><p>Overall, in both studies 75&nbsp;patients were observed for a treatment duration of more than 5&nbsp;years.</p><p>&nbsp;</p><p>The table presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level). Frequencies have been evaluated according to the following convention: very common (&ge;&nbsp;1/10), common (&ge;&nbsp;1/100&nbsp;to&nbsp;&lt;&nbsp;1/10), uncommon (&ge;&nbsp;1/1,000&nbsp;to&nbsp;&lt;&nbsp;1/100).</p><p>Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.</p><p><strong>&nbsp;</strong></p><p><strong>Table 2: Frequency of adverse drug reactions in clinical trials</strong></p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="height:28.05pt; vertical-align:top; width:199.85pt"><p><strong>MedDRA Standard </strong></p><p><strong>System Organ Class </strong></p></td><td style="height:28.05pt; vertical-align:top; width:133.3pt"><p><strong>Adverse reactions </strong></p></td><td style="height:28.05pt; vertical-align:top; width:120.45pt"><p><strong>Frequency </strong></p><p>&nbsp;</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>Blood and lymphatic system disorders</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>FVIII inhibition</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>Uncommon (PTPs)<sup>a</sup></p><p>&nbsp;</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>Immune system disorders</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Hypersensitivity</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>common</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>Psychiatric disorders</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Insomnia</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>common</p></td></tr><tr><td rowspan="3" style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>Nervous system disorders</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Headache</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>very common</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Dizziness</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>common</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Dysgeusia</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>uncommon</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>Vascular disorders</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Flushing</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>uncommon</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Cough</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>common</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>Gastrointestinal disorders</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Abdominal pain, Nausea, Vomiting</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>common</p></td></tr><tr><td rowspan="2" style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Erythema<sup>c</sup>, Rash<sup>d</sup></p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>common</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Pruritus</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>uncommon</p></td></tr><tr><td style="height:17.25pt; vertical-align:top; width:199.85pt"><p><strong>General disorders and administration site conditions</strong></p></td><td style="height:17.25pt; vertical-align:top; width:133.3pt"><p>Injection site reactions <sup>b</sup>, Pyrexia</p></td><td style="height:17.25pt; vertical-align:top; width:120.45pt"><p>common</p></td></tr></tbody></table><p style="margin-left:14.2pt; text-indent:-14.2pt"><sup>a</sup> Frequency is based on studies with all factor&nbsp;VIII products which included patients with severe haemophilia A. PTPs = previously-treated patients&rdquo;</p><p><sup>b</sup> includes injection site pruritus, injection site rash and vessel puncture site pruritus</p><p><sup>c</sup> includes erythema and erythema multiforme</p><p><sup>d</sup> includes rash and rash papular</p><p>&nbsp;</p><p>There was no change in the safety profile during the PROTECT&nbsp;VIII and the paediatric extension studies.</p><p>&nbsp;</p><p><u>Description of selected adverse reactions</u></p><p>&nbsp;</p><p><em>Immunogenicity</em></p><p>Immunogenicity was evaluated during clinical trials with Jivi in 159 (including surgery patients) previously treated adolescents (&ge;&nbsp;12&nbsp;years of age) and adults diagnosed with severe haemophilia&nbsp;A (FVIII:C &lt;&nbsp;1%), and &ge;&nbsp;150&nbsp;previous exposure days.</p><p>&nbsp;</p><p><em>FVIII inhibitors</em></p><p>No <em>de novo</em> or confirmed cases of inhibitor against factor&nbsp;VIII occurred. A single unconfirmed positive result of a low titre of factor&nbsp;VIII inhibitor (1.7&nbsp;BU/mL) was reported in one adult patient undergoing surgery.</p><p>&nbsp;</p><p><em>Anti&not;PEG antibodies</em></p><p>Immunogenicity against PEG with development of specific IgM anti-PEG antibodies was observed in one patient. The immune response was accompanied by a clinical hypersensitivity reaction after 4&nbsp;injections of Jivi. Antibodies to PEG disappeared after discontinuation of Jivi.</p><p>No clinical immune response to PEG resulting in loss of drug efficacy or hypersensitivity was observed from the 5<sup>th</sup> ED through the end of the extension studies.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>In completed clinical studies with 73&nbsp;paediatric PTPs &lt;&nbsp;12&nbsp;years (44&nbsp;PTPs &lt;&nbsp;6&nbsp;years, 29&nbsp;PTPs 6&not;&lt;&nbsp;12&nbsp;years), adverse reactions due to immune response to PEG were observed in children less than 6&nbsp;years of age. In 10&nbsp;of&nbsp;44&nbsp; patients (23%) in the age group of younger than 6&nbsp;years of age loss of drug effect due to neutralising anti-PEG antibodies during the first 4 exposure days was observed. In 3&nbsp;of&nbsp;44&nbsp; patients (7%), loss of drug effect was combined with hypersensitivity reactions (see section&nbsp;4.4). No triggers or predictors of the immune response to PEG could be identified.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>&nbsp;</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via</p><p>&nbsp;</p><p style="margin-left:0in; margin-right:14.65pt"><strong><em>Saudi Arabia</em></strong></p><p style="margin-left:0in; margin-right:14.65pt">The National Pharmacovigilance Centre (NPC).</p><p style="margin-left:0in; margin-right:14.65pt">SFDA Call Center: 19999</p><p style="margin-left:0in; margin-right:14.65pt">E-mail: npc.drug@sfda.gov.sa</p><p style="margin-left:0in; margin-right:14.65pt">Website: https://ade.sfda.gov.sa</p><p style="margin-left:0in; margin-right:14.65pt"><strong><em>Other GCC States:</em></strong></p><p style="margin-left:0in; margin-right:14.65pt">Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There was one case of overdose in the clinical trials. No adverse events were reported.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: antihaemorrhagics: blood coagulation factor&nbsp;VIII, ATC&nbsp;code: B02BD02.</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>&nbsp;</p><p>The factor&nbsp;VIII/von Willebrand factor complex consists of two molecules (factor&nbsp;VIII and von Willebrand factor) with different physiological functions. When infused into a patient with haemophilia, factor&nbsp;VIII binds to patient&rsquo;s von Willebrand factor. Activated factor&nbsp;VIII acts as a cofactor for activated factor&nbsp;IX, accelerating the conversion of factor&nbsp;X to activated factor&nbsp;X. Activated factor&nbsp;X converts prothrombin into thrombin. Thrombin then converts fibrinogen into fibrin and a clot can be formed. Haemophilia&nbsp;A is a sex-linked hereditary disorder of blood coagulation due to decreased levels or absence of factor&nbsp;VIII:C that results in bleeding into joints, muscles or internal organs, either spontaneously or as a result of accidental or surgical trauma. By replacement therapy the plasma levels of factor&nbsp;VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.</p><p>&nbsp;</p><p>Damoctocog alfa pegol is a PEGylated form of rFVIII. Site-specific PEGylation reduces clearance of factor VIII resulting in an extended half-life while maintaining the normal functions of the B-domain deleted rFVIII molecule (see section&nbsp;5.2). Damoctocog alfa pegol does not contain von Willebrand factor.</p><p>&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p>&nbsp;</p><p><em>Clinical studies</em></p><p>&nbsp;</p><p>A total of 232&nbsp;previously treated patients with severe haemophilia&nbsp;A have been exposed in the clinical trial program which included one phase I study and two phase II/III studies. One-hundred and fifty nine (159) subjects were &ge; 12&nbsp;years of age,</p><p style="margin-left:49.65pt; text-indent:-49.65pt">&nbsp;</p><p style="margin-left:49.65pt; text-indent:-49.65pt"><u>Phase II/III</u> (PROTECT VIII):The pharmacokinetics, safety and efficacy of Jivi for on demand treatment, prophylaxis with three regimens (two times per week 30-40&nbsp;IU/kg, every 5-days 45-60&nbsp;IU/kg and every 7-days 60&nbsp;IU/kg) and haemostasis during major surgeries were evaluated in a multi-national, open-label, uncontrolled, partially randomized study which was performed in compliance with the agreed Paediatric Investigation Plan. An extension study included patients completing the main study. The primary efficacy variable was annualized bleed rate (ABR).</p><p style="margin-left:49.65pt; text-indent:-49.65pt">&nbsp;</p><p style="margin-left:49.65pt">One hundred and thirty four male PTPs received at least one injection of Jivi (including 13&nbsp;subjects aged 12 to 17&nbsp;years of age) for prophylaxis (n=114) or on-demand treatment (n=20) for a period of 36&nbsp;weeks. A total of 121&nbsp;subjects received treatment during the extension study, 107&nbsp;subjects received prophylaxis and 14&nbsp;subjects on-demand treatment. Thirty-six subjects received prophylaxis treatment for &gt;&nbsp;5&nbsp;years up to 7.0&nbsp;years. Total median (range) time in study was 3.9&nbsp;years (0.8 &ndash; 7.0&nbsp;years) in all 121&nbsp;patients. Hemostasis during 20&nbsp;major surgeries in 17&nbsp;patients was evaluated in the surgery part.</p><p>&nbsp;</p><p style="margin-left:49.65pt; text-indent:-49.65pt"><u>Phase&nbsp;III (Paediatric):</u> Pharmacokinetics, safety, and efficacy of Jivi for three prophylaxis regimens (twice weekly, every 5 and every 7&nbsp;days) and treatment of breakthrough bleeds were evaluated in a multi-national, uncontrolled, open-label trial in 73&nbsp;paediatric patients (&lt;&nbsp;12&nbsp;years of age) during a period of 50&nbsp;EDs and at least 6&nbsp;months. This study has been performed in compliance with the agreed Paediatric Investigation Plan. Sixty one subjects (83.6%) completed the main study and 59&nbsp;patients continued in the optional extension study with a total median time in study of 5.8&nbsp;years (range&nbsp;1.0-6.6&nbsp;years).</p><p style="margin-left:49.65pt; text-indent:-49.65pt">&nbsp;</p><p><em>Prophylactic treatment in subjects &ge;12</em>&nbsp;<em>years</em></p><p>&nbsp;</p><p>During the main study period subjects were assigned to prophylaxis 2x/week (n=24), or randomized to every 5 days (n=43) or every 7&nbsp;days (n=43) or received on-demand treatment (n=20) with Jivi. Ninety nine of 110&nbsp;patients (90%) remained on the assigned regimen. Eleven patients in the every 7&nbsp;days arm increased frequency. The median dose for all prophylaxis regimens was 46.9&nbsp;IU/kg/injection. The median (Q1; Q3) ABR during prophylaxis was 2.09 (0.0; 6.1) for all bleeds and 0.0 (0;0 4.2) for spontaneous bleeds as compared to 23.4 (18; 37) total bleeds in the on-demand group. Forty-two out of 110 in the prophylaxis arms (38.2%) experienced no bleeding episode.</p><p>&nbsp;</p><p>During the extension study (median duration of 3.2 years, range 0.1-6.3 years), 23&nbsp;patients were treated 2x/week, 33&nbsp;patients every 5-days, 23&nbsp;patients every 7&nbsp;days during total time in the extension study and 28 patients changed treatment regimen. The median dose for prophylaxis was 47.8&nbsp;IU/kg. The overall median (Q1; Q3) total ABR was 1.49 (0.4; 4.8) and 0.75 (0.0: 2.9) for spontaneous bleeds in the combined prophylaxis groups and total ABR was 34.1 in the on-demand group.</p><p>Of note, ABR is not comparable between different factor concentrates and between different clinical studies.</p><p>&nbsp;</p><p><em>Treatment of bleeding</em></p><p>&nbsp;</p><p>Of the 702&nbsp;bleeding events treated with Jivi during the main study, 636 (90.6%) were treated with 1 or 2&nbsp;injections, thereof 81.1% with 1 injection. The median (range) dose per injection was 31.7&nbsp;IU/kg (14; 62). During the extension 1902 bleeds were treated with Jivi and&nbsp; 94.0% were controlled with 1 or 2&nbsp;injections, thereof&nbsp; 84.9% with 1&nbsp;injection. The median (range) dose was 37.9 (15; 64)&nbsp;IU/kg/injection.</p><p>&nbsp;</p><p><em>Perioperative Management</em></p><p><em>&nbsp;</em></p><p>A total of 20&nbsp;major surgical procedures were performed and assessed in 17&nbsp;patients. The median total dose for major surgeries was 219&nbsp;IU/kg (range: 50-1500 IU/kg, including postoperative period up to 3&nbsp;weeks). Perioperative haemostatic efficacy was rated as good or excellent during all major surgeries.</p><p>Additional 34&nbsp;minor surgeries were performed in 19&nbsp;patients. Hemostasis was assessed as good or excellent in all available cases.</p><p>&nbsp;</p><p><em>Paediatric population &lt; 12</em>&nbsp;<em>years of age</em></p><p><u>&nbsp;</u></p><p>The use of Jivi in children below 12&nbsp;years is not indicated (see section&nbsp;4.2, for information on paediatric use).</p><p>A total of 73&nbsp; previously treated pediatric patients (44&nbsp;subjects &lt; 6&nbsp;years and 29&nbsp;subjects 6&nbsp;to&nbsp;&lt;&nbsp;12&nbsp;years) received prophylaxis treatment twice weekly, every 5&nbsp;days or every 7&nbsp;days in the phase III study. For 53&nbsp;patients who completed the main study, the median (Q1; Q3) annualised bleeding rate was 2.87 (1.1; 6.1) and the spontaneous ABR was 0.0 (0.0; 2.6). For treatment of bleeds, 84.4&nbsp;% of the bleeds were resolved with 1&nbsp;injection, and 91.9% of the bleeds were resolved with 1&nbsp;or&nbsp;2&nbsp;injections.</p><p>11&nbsp;patients in the age group &lt;&nbsp;6&nbsp;years dropped out due to an immune response to PEG associated with loss of efficacy and/or hypersensitivity reaction during the first four ED.</p><p style="margin-left:0in; margin-right:0in">For 59&nbsp;patients who continued in the extension study the overall median (Q1; Q3) ABR during the extension period was 1.64 (0.5; 3.1). For 30&nbsp;patients &ge;&nbsp;12&nbsp;years at the end of the extension study, the median (Q1; Q3) ABR was 1.76 (0.5; 3.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:0in; margin-right:0in">The pharmacokinetics (PK) of Jivi was compared to that of factor&nbsp;VIII in a crossover Phase I study. PK was also evaluated in 22&nbsp;subjects (&ge;12&nbsp;yrs) and in 16 of these subjects after 6 months of prophylaxis treatment in the Phase II/III study.</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p>The PK data (based on chromogenic assay) indicated that Jivi has a reduced clearance (CL), resulting in a terminal half-life that is 1.4-fold longer and a dose normalized AUC which is 1.4-fold higher, as compared to the comparative factor&nbsp;VIII product. Dose proportional increases were observed between the doses of 25&nbsp;and 60&nbsp;IU/kg indicating dose linearity between 25&nbsp;IU/kg and 60&nbsp;IU/kg.</p><p>&nbsp;</p><p style="margin-left:0in; margin-right:0in">Table 3 summarizes the PK parameters after single dose of 60&nbsp;IU/kg from the Phase II/III study where PK was evaluated in 22&nbsp;subjects. Repeated PK measurements did not indicate any relevant changes in PK characteristics after long-term treatment.</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p>Table 3: Pharmacokinetic parameters (geometric mean (%CV) and arithmetic mean (&plusmn;SD)) for Jivi following a single 60&nbsp;IU/kg dose based on chromogenic assay.</p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="height:15.05pt; vertical-align:top; width:184.3pt"><p style="text-align:center"><strong>Parameters (units) </strong></p></td><td style="height:15.05pt; vertical-align:top; width:198.45pt"><p style="text-align:center"><strong>Jivi</strong></p><p style="text-align:center"><strong>Patients &ge;12 years</strong></p><p style="text-align:center"><strong>n=22</strong></p></td></tr><tr><td style="height:22.55pt; vertical-align:top; width:184.3pt"><p><strong>AUC (IU*h/dL)</strong></p></td><td style="height:22.55pt; vertical-align:top; width:198.45pt"><p style="text-align:center">3710 (33.8)<br />3900 &plusmn; 1280</p></td></tr><tr><td style="height:22.55pt; vertical-align:top; width:184.3pt"><p><strong>AUC, norm (h*kg/dL)</strong></p></td><td style="height:22.55pt; vertical-align:top; width:198.45pt"><p style="text-align:center">62.5 (33.7)<br />65.7 &plusmn; 21.4</p></td></tr><tr><td style="height:22.55pt; vertical-align:top; width:184.3pt"><p><strong>Cmax (IU/dL)</strong></p></td><td style="height:22.55pt; vertical-align:top; width:198.45pt"><p style="text-align:center">163 (14.7)<br />164 &plusmn; 23.8</p></td></tr><tr><td style="height:22.55pt; vertical-align:top; width:184.3pt"><p><strong>t&frac12; (h)</strong></p></td><td style="height:22.55pt; vertical-align:top; width:198.45pt"><p style="text-align:center">17.1 (27.1)<br />17.6 &plusmn; 4.26</p></td></tr><tr><td style="height:23.25pt; vertical-align:top; width:184.3pt"><p><strong>MRTIV (h)</strong></p></td><td style="height:23.25pt; vertical-align:top; width:198.45pt"><p style="text-align:center">24.4 (27.5)<br />25.2 &plusmn; 6.19</p></td></tr><tr><td style="height:23.25pt; vertical-align:top; width:184.3pt"><p><strong>Vss (dL/kg)</strong></p></td><td style="height:23.25pt; vertical-align:top; width:198.45pt"><p style="text-align:center">0.391 (16.3)<br />0.396 &plusmn; 0.0631</p></td></tr><tr><td style="height:23.25pt; vertical-align:top; width:184.3pt"><p><strong>CL (dL/h/kg)</strong></p></td><td style="height:23.25pt; vertical-align:top; width:198.45pt"><p style="text-align:center">0.0160 (33.7)<br />0.0168 &plusmn; 0.00553</p></td></tr></tbody></table><p style="margin-left:7.1pt; margin-right:0in">AUC: area under the curve; AUC, norm: dose normalized AUC C<sub>max</sub>: maximum drug concentration; ,</p><p style="margin-left:7.1pt; margin-right:0in">t<sub>&frac12;</sub>: terminal half&not;life; MRT <sub>IV</sub> : mean residence time after an intravenous administration; V<sub>SS</sub>: apparent volume distribution at steady&not;state; CL: clearance</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">Incremental recovery was determined in 131&nbsp;patients at several time points. The median (Q1; Q3) recovery was 2.6 (2.3; 3.0) by chromogenic assay.</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p style="margin-left:0in; margin-right:0in">A population PK model was developed based on all available factor&nbsp;VIII measurements (from dense PK sampling and all recovery samples) throughout the 3&nbsp;clinical studies allowing calculation of PK parameters for subjects in the various studies. The table 4 below provides PK parameters based on the population PK model.</p><p style="margin-left:0in; margin-right:0in">&nbsp;</p><p>Table 4:<u> </u>PK parameters (geometric mean [%CV]) based on population PK model, using chromogenic assay.</p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="height:27.95pt; vertical-align:top; width:108.3pt"><p>PK parameter(unit)</p></td><td style="height:27.95pt; vertical-align:top; width:92.15pt"><p>12-&lt;18 years</p><p>N=12</p></td><td style="height:27.95pt; vertical-align:top; width:92.15pt"><p>&ge; 18 years</p><p>N=133</p></td><td style="height:27.95pt; vertical-align:top; width:99.75pt"><p>Total (&ge;&nbsp;12&nbsp;years)</p><p>N=145</p></td></tr><tr><td style="height:23.1pt; vertical-align:top; width:108.3pt"><p>AUC (IU.h/dL)*</p></td><td style="height:23.1pt; vertical-align:top; width:92.15pt"><p>3341 (34.2)</p></td><td style="height:23.1pt; vertical-align:top; width:92.15pt"><p>4052 (31.1)</p></td><td style="height:23.1pt; vertical-align:top; width:99.75pt"><p>3997 (31.6)</p></td></tr><tr><td style="height:12.6pt; vertical-align:top; width:108.3pt"><p>AUCnorm (kg.h/dL)</p></td><td style="height:12.6pt; vertical-align:top; width:92.15pt"><p>57.4 (32.6)</p></td><td style="height:12.6pt; vertical-align:top; width:92.15pt"><p>67.5 (30.6)</p></td><td style="height:12.6pt; vertical-align:top; width:99.75pt"><p>66.6 (31.0)</p></td></tr><tr><td style="height:12.6pt; vertical-align:top; width:108.3pt"><p>t<sub>1/2 </sub>(h)</p></td><td style="height:12.6pt; vertical-align:top; width:92.15pt"><p>16.8 (25.2)</p></td><td style="height:12.6pt; vertical-align:top; width:92.15pt"><p>17.4 (28.8)</p></td><td style="height:12.6pt; vertical-align:top; width:99.75pt"><p>17.4 (28.4)</p><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td style="height:13.15pt; vertical-align:top; width:108.3pt"><p>Vss (dL/kg)</p></td><td style="height:13.15pt; vertical-align:top; width:92.15pt"><p>0.423 (15.5)</p></td><td style="height:13.15pt; vertical-align:top; width:92.15pt"><p>0.373 (15.6)</p></td><td style="height:13.15pt; vertical-align:top; width:99.75pt"><p>0.376 (15.9)</p></td></tr><tr><td style="height:12.6pt; vertical-align:top; width:108.3pt"><p>CL (dL/h/kg)</p></td><td style="height:12.6pt; vertical-align:top; width:92.15pt"><p>0.0174 (34.2)</p></td><td style="height:12.6pt; vertical-align:top; width:92.15pt"><p>0.0148 (31.1)</p></td><td style="height:12.6pt; vertical-align:top; width:99.75pt"><p>0.0150 (31.6)</p></td></tr></tbody></table><p>*AUC calculated for a dose of 60 IU/kg</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Jivi was evaluated in pharmacology, single and repeated dose as well as juvenile toxicity studies in rats and rabbits. In a long-term, 6-months chronic toxicity study no indication of PEG accumulation or other effects related to administration of Jivi were seen. In addition 4&nbsp;weeks toxicity studies with the PEG moiety of Jivi were conducted in two species. The PEG-linker moiety was also tested in a standard set of in vivo and in vitro genotoxicity studies and they did not indicate a potential for genotoxicity. These studies did not reveal any safety concerns for humans.</p><p>&nbsp;</p><p>Single dose studies in rats with the radio-labelled PEG moiety showed that there was no indication of retention or irreversible binding of radioactivity in the animal body. Specifically, no residual radioactivity was detected in the brain, indicating that the radio-labelled compound did not cross the blood brain barrier. In distribution and excretion studies in rats, the 60&nbsp;kDa PEG moiety of Jivi was shown to be widely distributed to and eliminated from organs and tissues, and excreted in urine (68.4% up to day&nbsp;231 after administration) and faeces (13.8% up to day&nbsp;168 after administration).</p><p>&nbsp;</p><p>No long-term studies in animals to evaluate the carcinogenic potential of Jivi, or studies to determine the effects of Jivi on reproduction have been conducted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Powder</u></p><p>Sucrose</p><p>Histidine</p><p>Glycine</p><p>Sodium chloride</p><p>Calcium chloride dihydrate</p><p>Polysorbate&nbsp;80</p><p>Acetic acid, glacial (for pH adjustment)</p><p><u>Solvent</u></p><p>Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products<em>.</em></p><p>&nbsp;</p><p>Only the components provided in the package should be used for reconstitution and injection because treatment failure can occur as a consequence of factor&nbsp;VIII adsorption to the internal surfaces of some injection equipment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened vial

2 years.

Reconstituted solution

The chemical and physical in-use stability after reconstitution has been demonstrated for 3 hours at room temperature. Do not refrigerate after reconstitution.
From a microbiological point of view the product should be used immediately after reconstitution. If not used immediately, the in-use storage times and conditions prior to use are the responsibility of the user.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&nbsp;&deg;C&nbsp;&not;&nbsp;8 &deg;C).</p><p>Do not freeze.</p><p>Keep the vial and the pre-filled&nbsp;syringe in the outer carton in order to protect from light.</p><p>&nbsp;</p><p>Within its overall shelf life of 2&nbsp;years, the product (when kept in its outer carton) may be stored at up to 25&nbsp;&deg;C for a limited period of 6&nbsp;months. The end date of the 6 month storage period at a temperature up to 25 &deg;C should be recorded on the product carton. This date should never exceed the expiry date printed on the outer carton. At the end of this period the product should not be put back in the refrigerator, but should be used or discarded.</p><p>&nbsp;</p><p>For storage conditions after reconstitution of the medicinal product, see section&nbsp;6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Each single package of Jivi contains:</p><p style="margin-left:28.35pt; margin-right:0in; text-indent:-28.35pt"><!--[if !supportLists]-->&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->one vial with powder (10&nbsp;mL clear type&nbsp;1 glass vial with grey bromobutyl rubber blend stopper and aluminium seal)</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->one pre-filled syringe with 2.5&nbsp;mL solvent (clear type&nbsp;1 glass cylinder syringe with grey bromobutyl rubber blend stopper)</p><p style="margin-left:28.35pt; margin-right:0in; text-indent:-28.35pt"><!--[if !supportLists]-->&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->one syringe plunger rod</p><p style="margin-left:28.35pt; margin-right:0in; text-indent:-28.35pt"><!--[if !supportLists]-->&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->one vial adapter (with integrated filter)</p><p style="margin-left:28.35pt; text-indent:-28.35pt"><!--[if !supportLists]-->&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->one venipuncture set</p><p>&nbsp;</p><p><u>Pack sizes</u></p><p style="margin-left:64.35pt; text-indent:-64.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->1 single pack.</p><p style="margin-left:64.35pt; text-indent:-64.35pt"><!--[if !supportLists]-->-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->1 multipack with 30 single packs.</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Detailed instructions for preparation and administration are contained in the package leaflet provided with Jivi.</p><p>&nbsp;</p><p>Jivi powder should only be reconstituted with the supplied solvent (2.5&nbsp;mL water for injections) in the prefilled-syringe and the vial adapter. The medicinal product must be prepared for injection under aseptic conditions. If any component of the package is opened or damaged, do not use this component.</p><p>After reconstitution the solution is clear and colourless and then drawn back into the syringe. Parenteral medicinal products should be inspected visually for particulate matter and discolouration prior to administration</p><p>&nbsp;</p><p>The reconstituted product must be filtered prior to administration to remove potential particulate matter in the solution. Filtering is achieved by using the vial adapter.</p><p>&nbsp;</p><p>Jivi is for single use only.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bayer AG
51368 Leverkusen
Germany

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                11/2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>